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Abstract 
 
The neuronal-specific potassium chloride co-transporter 2, KCC2, is a major 
chloride extruder in brain. The expression of KCC2 during neuronal 
development is fundamental to the switch of GABAergic response from 
excitatory to inhibitory. Malfunction of KCC2 can cause impairment of 
chloride homeostasis in neurons and is implicated in neurological disorders 
such as epilepsy. 
 
To date the role of protein phosphorylation in the regulation of KCC2 remains 
elusive. In this thesis, direct phosphorylation of KCC2 by PKC and Src 
tyrosine kinase was shown in vitro and in cultured neurons using the 
radioactive isotope 
32P. Single mutation of serine residue at position 940 in the 
intracellular domain of KCC2 (Ser
940) to alanine (S940A) blocked the 
phosphorylation of KCC2 under PKC activation. However, tyrosine 
phosphorylation of KCC2 was shown to not affect Tyr
1087, the putative tyrosine 
kinase phosphorylation site. To better understand phosphorylation of KCC2 at 
Ser
940, a phospho-specific antibody against this residue - namely p-S940 - was 
developed. Interestingly, agents inhibiting PKC and phosphatases altered signal 
of p-S940, indicating involvement of PKC, phosphatase-1 (PP1) and 
phosphatase-2A (PP2A) in the regulation of Ser
940 phosphorylation. In an in 
vitro method using p-S940, it was shown that PP1 and PP2A dephosphorylated 
KCC2. 
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To examine the functional effect of phospho-dependent modulation of KCC2, 
cell surface stability of KCC2 and its co-transport activity were determined. 
Notably, PKC activation increased cell surface expression of KCC2 by 
reducing its endocytosis, an effect blocked by S940A mutation. PKC activation 
also increased furosemide-sensitive [
86Rb
+] uptake in HEK-293 cells, 
indicating that PKC mediates KCC2 co-transport activity. Concomitantly, 
S940A mutation blocked the effect of PKC activation on its co-transport 
activity, while its basal activity remained intact. Together, this thesis describes 
direct phosphorylation of KCC2 and the functional detail of such 
phosphorylation in the regulation of KCC2 cell surface expression and co-
transport activity.   5
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Chapter 1  Introduction 
 
1.1  Classification of K
+-Cl
- co-transporters 
 
K
+-Cl
- co-transporters (KCC) belong to the superfamily cation chloride co-
transporters (CCC) that transport cation and chloride ions in the same direction 
across the cell membrane (Payne, 1997). Ion co-transporters exist throughout 
the whole body. They are important in many physiological processes such as 
cell volume regulation, excretion and neuronal communication (Gamba, 2005). 
KCCs exist in a wide range of organisms in the animal kingdom so their 
functions are evolutionarily conserved (Adragna et al., 2004). To date four 
members of the KCC family have been identified: KCC1, KCC2, KCC3 and 
KCC4. These transporters differ in their expression pattern and their molecular 
weight (Table 1). All KCC members are capable of transporting potassium and 
chloride ions across the cell membrane in a 1:1 stoichiometric ratio in the same 
direction; hence they are electroneutral (i.e. their activities do not alter 
membrane potential) (Gamba, 2005). Although KCCs are capable of 
transporting ions into or out of the cell, thermodynamically a net removal of 
ions is favored due to a concentration gradient driving potassium ions out; thus 
they are highly associated with regulatory cell volume control (Russell, 2000). 
Among different members of the KCC family, KCC2 is unique due to its 
neuronal-specific expression (Payne et al., 1996). Subsequently a single 
neuronal restrictive silencing element (NRSE) responsible for its neuronal 
specific expression has been identified within the KCC2 gene in human and 
mouse (Karadsheh and Delpire, 2001) (See also section 1.6). Physiologically    18
 
 
Table 1 Members and characteristics of the KCC family. 
  KCC1 KCC2 KCC3 KCC4 
Gene name  SLC12A4 SLC12A5  SLC12A6  SLC12A7 
Expression  Ubiquitously 
expressed 
Brain Brain,  heart, 
kidney 
Ubiquitously 
expressed 
Deduced 
molecular weight 
(kDa) 
120 123 127 120 
Activation by N-
ethylmaleimide 
(NEM) 
Yes Yes Yes Yes 
Response to 
change in 
osmolarity 
Yes Yes Yes Yes 
Sensitivity to 
furosemide (IC50) 
~200µM ~20µM  ~200µM ~1mM 
Major 
physiological 
function 
Cell volume 
regulation, cell 
cycle control 
Cl
- equilibrium 
potential in 
neurons, 
determining 
GABA reversal 
potential 
Arterial 
pressure 
regulation, 
development of 
inner ear, cell 
volume 
regulation 
K
+ re-
absorption in 
neurons, acid-
base 
metabolism 
Phenotype of 
knock-out animal 
(Not 
applicable) 
Postnatal death 
due to 
respiratory 
failure 
Hypertension, 
progressive 
hearing loss 
Deafness 
Associated 
disorders 
Cervical cancer  Epilepsy, 
neuropathic 
pain 
Anderman 
syndrome, 
hypertension, 
cervical cancer 
Cervical cancer 
   19
expression of KCC2 is related to the emergence of inhibition mediated by γ-
amino butyric acid type A receptor (GABAA receptor) during neuronal 
development (Rivera et al., 1999; Ben-Ari, 2002). The role of KCC2 in setting 
and maintaining Cl
- equilibrium potential in neurons and directly determining 
fast GABAergic inhibition has been confirmed by measuring the driving force 
of GABAA response in hippocampal slices after exposing to 
phosphorothionated oligodeoxynucleotides which knocked down KCC2 gene 
expression (Rivera et al., 1999) (Table 2). 
 
Similar to other KCC members, KCC2 is activated by the sulfhydryl agent N-
ethylmaleimide (NEM) and inhibited by loop diuretics such as furosemide and 
bumetanide (Payne, 1997). To date the detailed mechanisms of how these 
agents activate or inhibit KCC2 activities are not known but the region between 
TM2 and TM3 domains of KCC2, which shares high homology with other 
CCC members, is speculated to play a significant role (Gamba, 2005) (See also 
section 1.4). 
 
1.2  Molecular structure of KCC2 
 
KCC2 has been cloned in different species including rat, mouse and human 
(Gillen et al., 1996; Payne et al., 1996; Song et al., 2002). In rat, the KCC2 
gene is found in chromosome 3 with a locus position 3q42 (GenBank accession 
number Slc12a5). In mouse the gene is found in chromosome 8, and in humans 
it is found in chromosome 20. The SLC12A5 gene spans over 30kb in size and 
consists of 24 exons (Sallinen et al., 2001). A splice variant that encodes     20
 
 
 
 
 
 
Table 2 Expression of KCC2 in rat hippocampus and polarity of GABAA 
receptor mediated responses. Adapted from Rivera et al., 1999. 
Preparations (P, postnatal)  KCC2 expression  GABAA receptor responses 
P0-P4 Low  Depolarizing 
P>12 High  Hyperpolarizing 
P>12, exposed to KCC2 
antisense oligonucleotides 
Low ~0 
P>12, exposed to KCC2 
sense oligonucleotides 
High Hyperpolarizing 
   21
different 40 amino acid residues at its N-terminus was also identified recently; 
however it contributes only to 5-10% of total KCC2 mRNA in mature mice 
cortex (Uvarov et al., 2007). The complete coding sequence of rat KCC2 can 
be found in GenBank by accession number U55816. KCC2 molecules from rat 
are made of 1116 amino acids with a predicted molecular weight of 
approximately 123.6kDa (Payne, 1997) (Fig. 1.1). It has been proposed that 
KCC2 molecules consist of two major intracellular domains on both the N-tail 
(amino acid 1-102) and the C-tail (amino acid 635-1116), which are linked by 
12 transmembrane domains (Payne, 1997) (Fig. 1.2). Sequence comparison 
shows that KCC2 shares 67% identity with KCC1 and 25% identity with 
sodium potassium chloride co-transporters (NKCC) (Russell, 2000; Gamba, 
2005). 
 
Intracellular N-tail and C-tail 
 
The intracellular N-tail and C-tail of KCC2 are hydrophilic and account for 
50% of the molecular mass of this protein (Williams et al., 1999). These 
intracellular regions are believed to harbor regulatory sites for the co-
transporter; for example, putative sites for PKC phosphorylation (Thr
34, Ser
728, 
Thr
787, Ser
940 and Ser
1034) and that for tyrosine kinase phosphorylation (Tyr
1087) 
have been documented (Payne et al., 1996; Strange et al., 2000) (Fig. 1.2). 
Interestingly, Ser
940 is found in a region unique to KCC2 among all other KCC 
family members due to an insertion of an extra exon in the SLC12A5 gene, 
while Tyr
1087 is highly conserved among them (Payne et al., 1996) (Fig. 1.3). 
Within this unique region of KCC2 protein, a stretch of 15 amino acids, an   22
 
 
MLNNLTDCEDGDGGANPGDGNPKESSPFINSTDTEKGREYDGRNMALFEEEMDT
SPMVSSLLSGLANYTNLPQGSKEHEEAENNEGGKKKPVQAPRMGTFMGVYLPCL
QNIFGVILFLRLTWVVGIAGIMESFCMVFICCSCTMLTAISMSAIATNGVVPAGGSYYM
ISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEILLAYLFPAMAIFKAEDASGEAAAM
LNNMRVYGTCVLTCMATVVFVGVKYVNKFALVFLGCVILSILAIYAGVIKSAFDPPNF
PICLLGNRTLSRHGFDVCAKLAWEGNETVTTRLWGLFCSSRLLNATCDEYFTRNNVTE
IQGIPGAASGLIKENLWSSYLTKGVIVERRGMPSVGLADGTPVDMDHPYVFSDMTSYF
TLLVGIYFPSVTGIMAGSNRSGDLRDAQKSIPTGTILAIATTSAVYISSVVLFGACIEGVV
LRDKFGEAVNGNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAISRDGIVP
FLQVFGHGKANGEPTWALLLTACICEIGILIASLDEVAPILSMFFLMCYMFVNLACAVQ
TLLRTPNWRPRFRYYHWTLSFLGMSLCLALMFICSWYYALVAMLIAGLIYKYIEYRG
AEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLVRVDQDQNVVHP
QLLSLTSQLKAGKGLTIVGSVLEGTFLDNHPQAQRAEESIRRLMEAEKVKGFCQV
VISSNLRDGVSHLIQSGGLGGLQHNTVLVGWPRNWRQKEDHQTWRNFIELVRET
TAGHLALLVTKNVSMFPGNPERFSEGSIDVWWIVHDGGMLMLLPFLLRHHKVW
RKCKMRIFTVAQMDDNSIQMKKDLTTFLYHLRITAEVEVVEMHESDISAYTYEKT
LVMEQRSQILKQMHLTKNEREREIQSITDESRGSIRRKNPANTRLRLNVPEETACD
NEEKPEEEVQLIHDQSAPSCPSSSPSPGEEPEGEGETDPEKVHLTWTKDKSAAQKN
KGPSPVSSEGIKDFFSMKPEWENLNQSNVRRMHTAVRLNEVIVNKSRDAKLVLLN
MPGPPRNRNGDENYMEFLEVLTEQLDRVMLVRGGGREVITIYS 
 
Fig. 1.1 Amino acid sequence of rat KCC2. Sequence is obtained from 
GenBank accession number U55816. The 2 major intracellular domains (N-tail, 
amino acid 1-102, and C-tail, amino acid 635-1116) are in bold face, 12 
transmembrane domains are underlined, sites predicted to be phosphorylated 
by PKC are highlighted in red (Thr
34, Ser
728, Thr
787, Ser
940 and Ser
1034) while 
the site putatively phosphorylated by tyrosine kinase is denoted in blue 
(Tyr
1087).   23
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Fig. 1.2 Molecular organization of KCC2. Membrane-bound KCC2 
molecules consist of two major intracellular domains at N-tail (amino acid 1-
105) and C-tail (amino acid 635-1116) in which putative phosphorylation sites 
by PKC and tyrosine kinase can be found. There are twelve transmembrane 
domains and a major N-linked glycosylated extracellular domain between TM5 
and TM6.   24
 
 
 
 
 
Thr34 Ser728 Thr787
KCC1 SPFLSPLEASRGIDYYD----GEAQAAEQTIKNMMEIE----WRQSEDPRAKWTFIDTV
KCC2 SPFINSTDTEKGKEYDG----PQAQRAEESIRRLMEAE----WRQKEDHQTWRNFIELV
KCC3 NAYLNNSNYEEGDEYFD----GEALAAEQTIKHLMEAE----WRQSEDARAWKTFIGTV
KCC4 SPFLNNVEVEQESFFEG----MEAQRAEENIRSLMSTE----WKQEDNPFSWKNFVDTV
..::.  : ..   : .     :*  **:.*: :*. *    *:*.::  :*:.*:  *
Ser940 Ser1034 Tyr1087
KCC1 ---------------------PDNFRELVHIKPD--------RNSEGDENYMEFLEVLT
KCC2 SITDESRGSIRRKNPAN----SEGIKDFFSMKPEWENL----RNRNGDENYMEFLEVLT
KCC3 ---------------------MEGFQDLLNMRPD--------RNPEGDENYMEFLEVLT
KCC4 ---------------------LSGFKDLFSMKPD--------KNRQGDENYMEFLEVLT
..::::. ::*:        :* :*************
KEY:
* = Identity
: = Strongly similar
. = Weakly similar
 
 
Fig. 1.3 Sequence alignments of KCC family members at putative 
phosphorylation sites of KCC2. Eight amino acids before and after the 
phosphorylation sites on KCC2 (colored red for PKC phosphorylation sites and 
blue for tyrosine kinase phosphorylation site) are shown. Sequence homology 
among KCC1 to KCC4 are indicated as identity (*), strongly similar (:) and 
weakly similar (.).   25
“ISO segment”, was identified as responsible for its constitutive activity in 
isotonic conditions (Mercado et al., 2006). In addition, regions in the C-tail 
have been identified as interacting with potential regulatory effectors (Bergeron 
et al., 2006) and cytoskeleton-associated proteins (Li et al., 2007). The C-tail of 
KCC2 is thus believed to play important roles in regulation of co-transport 
function by cell signaling molecules such as kinases and maintenance of 
structural integrity of neuronal dendrites (Li et al., 2007) (See also section 1.5). 
 
Transmembrane domains 
 
There are 12 putative transmembrane (TM) domains in KCC2 molecules 
(Williams et al., 1999). These regions display the highest identity (>90%) 
between KCC1 and KCC2. In particular, TM2 and TM3 are highly conserved 
among CCC family members (Payne et al., 1996). These regions may also be 
involved in determining ion affinity and bumetanide binding of KCC2 as 
demonstrated by other CCC family members (Russell, 2000). 
 
Extracellular loop 
 
There is a prominent extracellular loop between TM5 and TM6 of KCC2 
which is glycosylated at four positions as predicted (Payne et al., 1996; 
Williams et al., 1999) (Fig. 1.2). The exact function of glycosylation is 
unknown, but it may be involved in the modification of co-transport activities. 
The glycosylation increases apparent molecular weight of KCC2 from 123kDa 
to around 145kDa in the expression systems (Williams et al., 1999). This   26
molecular weight can be reduced in size by N-glycosidase (Williams et al., 
1999). 
 
1.3  Expression of KCC2 
 
KCC2 can be found in different parts of the central nervous system. A range of 
experimental techniques have been used to demonstrate the expression of 
KCC2. For example, protein expression of KCC2 has been detected with 
techniques such as western blotting and immunohistochemistry in cortex 
(Bayatti et al., 2007; Molinaro et al., 2007), retina (Vardi et al., 2000; Vu et al., 
2000) and cochlear nucleus (Vale et al., 2005); KCC2 protein expression with 
electron microscopy in hypothalamus (Belenky et al., 2008); KCC2 mRNA 
with in situ hybridization in temporal lobe (Huberfeld et al., 2007) and spinal 
cord (Vinay and Jean-Xavier, 2008). Interestingly, KCC2 is found to express 
heavily in the inferior colliculus (Reid et al., 2001) and dentate gyrus (Pathak et 
al., 2007), brain regions that are highly associated with epileptic seizures. This 
suggests a correlation between KCC2 and epilepsy. Furthermore, KCC2 has 
been found to express in the hypothalamic suprachiasmatic nucleus, the 
primary circadian clock in mammals which regulates rhythmic behavior and 
physiology (Belenky et al., 2008). 
 
KCC2 is neuronal specific and its expression is central to the inhibitory 
function of GABAA receptors (Rivera et al., 1999). An NRSE has been 
identified within the intron 1 of mouse KCC2 gene (Karadsheh and Delpire, 
2001). More recently, a 1.4kb promoter region directly upstream of KCC2 gene   27
has been identified in mouse to be sufficient for neuronal-specific expression 
(Uvarov et al., 2005). The role of KCC2 in Cl
- efflux has also been 
demonstrated using recombinant expression (Payne et al., 1996; Strange et al., 
2000; Bergeron et al., 2006). Significantly, measurement of the reversal 
potential of GABA has demonstrated that expression of KCC2 is essential to 
the inhibitory action of GABAA receptors (Rivera et al., 1999). It has now been 
established that KCC2 is the major Cl
- extruder in the central nervous system 
and that it is directly related to the transition in response to GABA from 
depolarization in the prenatal stage (when [Cl
-]i is above its electrochemical 
potential equilibrium) to hyperpolarization in the postnatal period (when [Cl
-]i 
is below this equilibrium) (Rivera et al., 1999). 
 
Expression of KCC2 under the regulation of neuronal transmission had been 
investigated but remained elusive. It has been shown that expression of KCC2 
is not affected by blocking either glutamatergic transmission or action potential 
(Ganguly et al., 2001; Ludwig et al., 2003). However, there is contradictory 
evidence both to support (Ganguly et al., 2001) and deny (Ludwig et al., 2003) 
the notion that GABAergic transmission regulates KCC2 expression during 
neuronal development. Despite this conflicting evidence, brain-derived 
neurotrophic factor (BDNF) may play a role in regulating postsynaptic 
transmission by down-regulating KCC2 expression (Rivera et al., 2002; Wardle 
and Poo, 2003). A positive shift in the reversal potential for Cl
- and a less 
inhibitory GABAergic current was observed when BDNF was applied during 
hippocampal slice recordings (Rivera et al., 2002). 
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1.4  Pharmacology of KCC2 
 
KCC2 can be activated by 1mM NEM, possibly through a sulfhydryl 
modification of the co-transporter or an associated protein, although the 
binding site for NEM has not been identified on KCC2 molecules (Lauf, 1985; 
Gamba, 2005). On the other hand, KCC2 can be inhibited by loop diuretics and 
is more sensitive to furosemide (20µM) than to bumetanide (55 µM); however, 
to date there is no selective inhibitor of KCC2 (Payne, 1997). Inhibition of 
KCC2 by loop diuretics is possibly controlled by a region close to TM2 and 
TM3 domains of KCC2, which shares the highest homology among different 
CCC members and is known to be responsible for cation binding in NKCC2 
(Gagnon et al., 2004). To date the ability of NEM or loop diuretics to cross the 
blood-brain barrier is not known. There is also no known pharmacological 
agent to modify KCC2 activities in vivo. Unlike other KCC members, KCC2 
exhibits constitutive activity in isotonic conditions, and does not require 
activation by cell swelling (Payne, 1997). 
 
1.5  Functional significance of KCC2 
 
Cellular homeostasis 
 
The activity of KCC2 is defined as secondary active transport, since its activity 
derives from the intracellular concentration of K
+, [K
+]i, but not from the 
availability of adenosine triphosphate (ATP) (Payne, 1997). This is particularly 
important since KCC2 is energy independent; ionic balance controlled by this   29
co-transporter can be carried out even when energy is not readily available. 
Activity of KCC2 is also electroneutral, since both K
+ and Cl
- are transported 
in a 1:1 stoichiometry. This enables KCC2 to carry out its function without 
affecting the electrical property of neurons. When ions are transported across 
the neuronal membrane, water molecules are also moved due to osmotic action. 
KCC2 thus plays a role in the homeostasis of neurons by controlling water 
movement during ion transport (Gamba, 2005). 
 
K
+ buffering 
 
The high affinity of KCC2 for extracellular K
+ can be reflected by its Km value 
(5.2mM) compared to that of KCC1 (25mM). KCC2 is therefore able to 
respond to subtle changes in extracellular concentration of K
+ ([K
+]o) which 
indicates that KCC2 is a strong K
+ buffer for neuronal transmission (Payne, 
1997). During neuronal transmission, outward K
+ movement from neurons 
leads to a fall in intracellular concentration of K
+ ([K
+]i). To prevent depletion 
of [K
+]i there are several mechanisms to return K
+ back into neurons including 
Na
+-K
+-ATPase and glial spatial buffering (Walz, 1989). Since KCC2 has a 
high affinity for an extracellular concentration of K
+ ([K
+]o), a subtle increase 
in [K
+]o after neuronal depolarization results in a shift of equilibrium of K
+ and 
Cl
- and a net influx of both ions is favored (Payne, 1997) (Fig. 1.4). This serves 
as a mechanism for neurons to respond to depletion of [K
+]i. 
 
Maintenance of Cl
- equilibrium potential, ECl   30
 
 
 
 
 
 
Fig. 1.4 Thermodynamic driving force of KCC2 (J/mol) as a function of 
[K
+]o at various [Cl
-]i values. Adapted from Payne, 1997. At a physiological 
concentration of [Cl
-]i such as 7mM, a change of [K
+]o from a low value 
(<5mM) to a high value (>5mM) will induce net influx of ions.   31
Co-localization of KCC2 and GABAA receptor β2/β3 subunits shown by 
immunofluorescence microscopy suggests that KCC2 is highly associated with 
GABAergic functions (Williams et al., 1999). Concentration of Cl
- in neurons 
is maintained by ion co-transporter systems including NKCC1 and KCC2 
(Gamba et al., 1994; Haas and Forbush, 1998; Mount et al., 1998; Russell, 
2000). The former is an ion importer while the latter is an exporter. The 
relative activities of these co-transporters determine the Cl
- gradient across the 
neuronal membrane, which contributes to ECl. In particular, during neuronal 
development protein expression of NKCC1 is lowered at the postnatal stage 
and that of KCC2 is increased approximately 10 days after birth (Li et al., 2002; 
Wang et al., 2002; Delpy et al., 2008). These changes in expression of co-
transporters reduce [Cl
-]i in adult animal and lower ECl, which in turn renders 
GABA inhibitory (Owens et al., 1996; Ehrlich et al., 1999; Rivera et al., 1999). 
In the brain differential expression of KCC2 gives rise to altered ECl and thus to 
an altered GABAergic response; for example, GABAA reversal potential is less 
negative and less hyperpolarizing in dopaminergic neurons than in GABAergic 
neurons due to lower KCC2 expression in the former type of neuron (Gulacsi et 
al., 2003). 
 
Neuronal development 
 
It is now accepted that KCC2 plays an important role in neuronal development, 
functioning as a molecular switch to alter fast synaptic signaling (Rivera et al., 
2005). As described above, GABA transmission is mainly excitatory prenatally. 
It has been speculated that Ca
2+ signaling during the excitatory response of the   32
GABAA receptor in the early developmental stage is important in establishing 
the neuronal network. Studies show that protein expression of KCC2 is 
important for establishing the GABAergic synapse (Chudotvorova et al., 2005). 
The GABAergic network is thought to be constructed and stimulated by the 
lowering of [Cl
-]i by the functional expression of KCC2. Recently KCC2 has 
been found to interact with the spine cytoskeleton 4.1N through which synaptic 
spine maturation is promoted (Li et al., 2007). Interestingly, expression of the 
non-chloride-extruding form of KCC2 lacking its N-terminal intracellular 
domain is able to restore the formation of spine and functional synapse in 
KCC2-deficient mice (Li et al., 2007). The development of spine is thus 
independent of its co-transport function and KCC2 is important for neuronal 
transmission, development and survival of neurons. 
 
Cell volume regulation and survival of neurons 
 
Cell volume change is one of the hallmarks of cell progression to apoptosis or 
proliferation. For example, KCC1, KCC3 and KCC4 are involved in 
erythropoiesis (De Franceschi et al., 2007). KCC1 is also known to play an 
important role in cell volume regulation due to its ubiquitous expression 
(Gamba, 2005). In brain, KCC2 is found to play a classical role in cell volume 
regulation. It has been shown that dendritic swelling caused by neuronal 
excitation is opposed by KCC2 activity (Gulyas et al., 2001). The fact that 
KCC2 is more sensitive to osmolarity than are other members in its family and 
is more sensitive to [Cl
-]i indicates that a tight control over the hyperpolarizing   33
effects of GABA is important for neurons (Bergeron et al., 2006). A schematic 
diagram showing different functions of KCC2 can be found in Fig. 1.5. 
 
1.6 Regulation  of  KCC2 
 
Since KCCs play important roles in a number of different physiological 
processes, their regulation inside cells is important; for example, maintenance 
of activity of KCC2 is essential in keeping the transmembrane Cl
- gradient in 
neurons. To date, the regulation of KCC2 in neurons is not well understood. 
Studies on KCC2 have focused on transcriptional regulation and post-
translational modification. 
 
Transcriptional regulation 
 
KCC2 is unique among all other KCC members in being neuronal-specific. To 
identify elements in the KCC2 gene that confer its neuronal-specific expression, 
an NRSE has been identified within intron 1 of the KCC2 gene (Karadsheh and 
Delpire, 2001). This unique element of KCC2 has been shown to silence 
reporter gene activity in non-neuronal cells. Furthermore, a 21-base pair region 
of this NRSE was found to share 80% homology with the consensus binding 
sequence of neuronal restrictive silencing factor and to bind to extracted 
nuclear proteins from mouse neural progenitor cell line C17. The early growth 
factor 4 (Egr4) binding element has been identified in this promoter region and 
it binds to Egr4 proteins in a mobility shift assay (Uvarov et al., 2006). It has 
been shown that antisense knockdown of Egr4 or expression of dominant     34
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Fig. 1.5 Functional significance of KCC2. Schematic diagram summarizing 
different functional aspects of KCC2 in neurons. Capable of transporting K
+ 
and Cl
- across neuronal membrane, KCC2 is responsible for establishment and 
maintenance of the Cl
- equilibrium potential (ECl) that renders GABA 
inhibitory, ionic homeostasis, K
+ buffering during neuronal transmission, 
neuronal development and survival and cell volume regulation.   35
negative form of Egr4 down-regulates KCC2 protein expression in neurons. 
This indicates an important role for this factor in developmental up-regulation 
of KCC2 gene expression. 
 
Post-translational modification 
 
A few studies show that KCC2 is regulated by phosphorylation. Brain type 
creatine kinase (CKB) has been reported to interact with KCC2 (Inoue et al., 
2004) and activate KCC2 function in HEK-293 cells (Inoue et al., 2006). CKB 
is an ATP-generating enzyme and plays critical role in energy support in cells 
(Mahajan et al., 2000). Interestingly, lowered CKB activity has been linked to 
neurological disorders such as Alzheimer’s disease and schizophrenia (Smith et 
al., 1991; Burbaeva et al., 2003). KCC2 may thus play a role in these CKB-
mediated diseases. In addition, tyrosine phosphorylation of KCC2 has been 
linked to the regulation of KCC2 cell surface stability and activity during 
neuronal stress (Wake et al., 2007). A loss of tyrosine phosphorylation of 
KCC2 reduces its cell surface stability and co-transport function. Furthermore, 
activity of WNK3 kinase, a member of the WNK family of serine/threonine 
kinases, is shown to down-regulate KCC2 (Kahle et al., 2005). In addition, 
mutation studies of KCC2 have revealed that the region around Ser
940 of the C-
tail intracellular domain of KCC2 is responsible for regulation by effector 
proteins that are mediated by PKC activation (Bergeron et al., 2006).However, 
in these studies direct phosphorylation of KCC2 mediated by WNK3 or PKC 
was not shown. The role of phosphorylation in regulation of KCC2 cells 
surface stability and activity thus remains elusive.   36
 
Phosphorylation is an ubiquitous mode of post-translational modification that 
regulates protein-protein interactions, protein activities and intracellular 
trafficking (Brandon et al., 2000; Kuramoto et al., 2007); for example, 
regulation of GABAA and GABAB receptors by phosphorylation has been 
investigated extensively (Fairfax et al., 2004; Jovanovic et al., 2004; Houston 
et al., 2007). It has been shown that phosphorylation increases the efficacy of 
GABA (Kanematsu et al., 2006), channel opening frequency of GABAA 
receptors (Porter et al., 1990), and receptor interaction with proteins such as 
clathrin adaptor protein complex AP2 (Kittler et al., 2008). Since KCC2 
controls transmembrane Cl
- potential, which in turn determines the polarity of 
GABA currents, regulation of KCC2 function is likely to have a profound 
effect on GABAergic transmission. The effect of phosphorylation on KCC2 
molecules is thus of particular interest in regards to the regulation of inhibitory 
transmission in the brain. 
 
1.7  Role of protein kinase C (PKC) in the regulation of neuronal 
inhibition 
 
PKC is abundantly expressed in brain and its activity is highly associated with 
neuronal function including excitation (Sheng et al., 1998; Belousov et al., 
2002), inhibition (Staley, 1994; Brandon et al., 2002) and long term 
potentiation (Madison et al., 1991). PKC regulates both pre-synaptic (Shuntoh 
et al., 1989; Macek et al., 1999) and post-synaptic (Malinow et al., 1989) 
processes and therefore exerts tight regulation on neuronal transmission.   37
 
In the central nervous system fast synaptic inhibition is carried out mainly 
through the activation of GABAA receptors, leading to the influx of Cl
- due to 
its negative equilibrium potential. PKC is involved extensively in such GABA-
mediated neuronal inhibition. Pre-synaptically PKC affects release of GABA 
into the synaptic cleft (Taniyama et al., 1990) and its re-uptake into the pre-
synaptic compartment (Cupello et al., 1993). GABA transporter GAT1 is also 
regulated by PKC in recombinant system (Sato et al., 1995). Furthermore, 
interaction between GABA transporter and syntaxin 1A is regulated by PKC 
activity (Beckman et al., 1998). Post-synaptically activation of PKC increases 
Cl
- permeation (Rapallino et al., 1993). PKC has also been found in different 
studies to regulate GABAA receptors (Brandon et al., 1999; Brandon et al., 
2000; Jovanovic et al., 2004). PKC thus plays an important role in the 
regulation of neuronal inhibition. 
 
To date, the role of PKC in the regulation of neuronal inhibition mediated 
through GABAA receptors has been investigated extensively. It has been shown 
that GABAA receptors are directly associated and phosphorylated by PKC in 
vitro and in neurons (Brandon et al., 1999; Brandon et al., 2000). Several 
residues of β and γ subunits of GABAA receptors have been identified as PKC 
substrates. β1 subunit of GABAA receptor has been found to be phosphorylated 
by PKC at its residue Ser
409 (Moss et al., 1992). Subsequently Ser
410 of β2 and 
Ser
408, Ser
409 of β3 subunits have been shown to be PKC substrates (McDonald 
and Moss, 1997). In addition, Ser
327 of γ2 subunit has been shown to be 
phosphorylated by PKC (Moss et al., 1992). Phosphorylation of these residues   38
results in modifications of receptor trafficking, channel opening properties and 
interactions of their associated binding proteins (Brandon et al., 1999; Brandon 
et al., 2000; Brandon et al., 2002; Jovanovic et al., 2004; Kittler et al., 2005). It 
has been established that binding of AP2 complex to β3 subunit of GABAA 
receptors occurs in a motif in which PKC phosphorylation site is found (Kittler 
et al., 2005). Phosphorylation at this site inhibits binding of AP2 and thus 
slows down endocytosis and enhances the efficacy of GABAergic transmission 
(Kittler et al., 2005). 
 
Studies have suggested that phosphorylation may play a role in regulating 
KCC2 functions. Putative PKC phosphorylation sites are found within the 
intracellular domains of KCC2 (Fig. 1.1, 1.2). Intriguingly, mutation studies 
showed that the phosphorylation site at position Ser
940 is involved in co-
transport activity in isotonic condition (Bergeron et al., 2006). PKC is thus a 
candidate to regulate KCC2 function by directly phosphorylating this co-
transporter. 
 
1.8  Endocytosis is a process modulating cell surface protein stability 
 
Cell surface protein expression is affected by the rate of endocytosis, 
degradation and re-cycling. To date, the mechanism of endocytosis mediated 
through the clathrin-coated vesicle is well characterized (Le Roy and Wrana, 
2005). It is a major pathway for the internalization of cell surface proteins. 
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Clathrin-mediated endocytosis is a process through which proteins at the cell 
surface are transported to the intracellular domain for subsequent degradation 
or recycling. A crucial step in this process is the recruitment of clathrin protein 
to plasma membrane by the interaction between clathrin and AP2 complex. 
There are four identified adaptor protein complexes (AP1-4) and they all play 
roles in the regulation of protein trafficking; however, AP2 is unique in that it 
plays a role in the formation of clathrin-coated vesicles from cell surface 
(Owen et al., 2004). AP2 is hetero-tetrameric, consisting of α, β2, μ2 and σ 
subunits. Among these subunits β2 has been shown to interact directly with 
clathrin proteins while μ2 is responsible for the interaction of specific amino 
acid sequence motifs within the cytoplasmic domain of membrane proteins 
(Collins et al., 2002). Identification of sequence motifs in membrane proteins 
for AP2 binding is thus important in hypothesizing whether a protein is likely 
undergoing clathrin-mediated endocytosis. 
 
There are several identified consensus sequence motifs for the endocytosis of 
cell surface proteins. A classical example is the NPXY motif (Asparagine-
Proline-X-Tyrosine where X represents any amino acid residue) which was 
identified as the signal for internalization of LDL receptor, integrins and the β-
amyloid precursor protein (Bonifacino and Traub, 2003). In addition, the 
YXXØ motif (Tyrosine-X-X-Ø where Ø represents any bulky hydrophobic 
amino acid) was also identified as an important internalization signal of 
membrane proteins including the transferrin receptor. In the sequence of KCC2, 
the YXXØ motif is found from amino acid 1087 to 1090 (YMEF) which   40
contains the putative tyrosine phosphorylation site Tyr
1087. It is thus important 
to investigate whether this site is involved in internalization of KCC2. 
 
1.9  KCC2 and neurological disorders 
 
Since KCC2 plays an important role in homeostasis and neuronal transmission, 
impaired expression of KCC2 during development or malfunction of KCC2 in 
mature neurons has been related to various neurological disorders. 
 
Epilepsy 
 
The role for KCC2 in epileptogenesis has been inferred due to its function as 
the major Cl
- extrusion mechanism in mature neurons. Compromised 
GABAergic synaptic transmission and excess excitability is often observed in 
both humans and in animal models of epilepsy (Treiman et al., 1990; 
Lowenstein and Alldredge, 1998; Coulter, 2001). This pathophysiology may be 
due to a reduced functional expression of KCC2 such that a normal ECl is not 
maintained (Fig. 1.6). Consistent with this reduced KCC2 mRNA levels, 
impaired Cl
- extrusion have been observed in various seizure models (Reid et 
al., 2001; Rivera et al., 2002; Rivera et al., 2004; Jin et al., 2005). Jin et al. has 
been able to show, using a gramicidin-perforated patch clamp technique, that 
chronically injured cortex is less effective in maintaining low [Cl
-]i during 
repetitive activation of GABAA receptor due to impaired KCC2 expression. In 
addition, disruption of the KCC2 gene leads to hyperexcitability in mice (Woo 
et al., 2002). Agents that modulate KCC2 activity have also been shown to    41
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Fig. 1.6 Compromised KCC2 activity and epilepsy. In mature neurons, 
KCC2 maintains low [Cl
-]i by transporting Cl
- out of intracellular domains. 
This action produces a negative ECl such that activation of GABAA receptors 
results in an influx of Cl
- and a subsequent inhibitory synaptic response. 
Increased neuronal activities increase [K
+]o level and decrease outward flux of 
K
+ and Cl
- directed by KCC2 activity such that ECl is shifted towards positive. 
In epilepsy, a loss of KCC2 function is observed that promotes an 
accumulation of intracellular Cl
- and ECl becomes positive. Activation of 
GABAA receptor results in an outflux of Cl
- and an excitatory response.   42
decrease seizure activity in rats (Reid et al., 2000). In addition BDNF, which is 
shown to be related to the developmental up-regulation of KCC2 and 
modulation of the GABAergic response (Aguado et al., 2003; Wardle and Poo, 
2003), is implicated in epileptogenesis (Binder et al., 2001). An in vivo knock-
in study of TrkB receptor, which is activated by BDNF, showed that activation 
of this receptor may play opposite roles in regulating KCC2 expression 
mediated through Shc (increased KCC2 expression) and CREB (decreased 
KCC2 expression) (Rivera et al., 2004). Together these studies show that there 
is a linkage between epilepsy and malfunction of KCC2. 
 
Neuropathic pain 
 
Diabetes-induced neuropathic pain has been associated with hyperexcitability 
and spontaneous hyperactivity in spinal cord neurons. It has been shown that, 
in a streptozotocin-induced diabetes rat model in which insulin-producing 
pancreatic beta-cells are damaged, expression of KCC2 is significantly reduced 
but expression of GABA is elevated in the dorsal horn laminae (Morgado et al., 
2008). This combined effect is likely to exaggerate the depolarization response 
of GABA. Such a loss of GABA-mediated inhibitory tone at the spinal cord 
may result in neuronal hyperexcitability and spontaneous hyperactivity in 
diabetes. Furthermore, local blockade of KCC2 using 
[(dihydroindenyl)oxy]alkanoic acid, DIOA, or knock-down of spinal KCC2 
using antisense oligodeoxynucleotides, also reduces the nociceptive threshold 
in rats (Coull et al., 2003). Using thermal and mechanical stimuli, investigators 
were able to show that knock-down of KCC2 decreases the latency for rats to   43
withdraw their paws, indicating increased pain sensation. Together these 
suggest that malfunction of KCC2 leading to an abnormal Cl
- gradient and 
subsequent GABA-mediated depolarization is the underlying mechanism of 
abnormal excitability in the pathophysiology of neuropathic pain. Novel 
therapeutic strategies to restore normal KCC2 function can be valuable to 
ameliorate this disorder. 
 
1.10  Aims of this study 
 
Whilst it has been suggested that phosphorylation modulates KCC2 activity, 
regulation of KCC2 by direct phosphorylation remained elusive. There is no 
evidence showing that KCC2 is directly phosphorylated (Strange et al., 2000; 
Adragna et al., 2004; Bergeron et al., 2006; Wake et al., 2007). Based on the 
current understanding of regulation of KCC2, it is hypothesized that KCC2 is 
phosphorylated by kinases and that this action affects its co-transport activity. 
A possible mechanism affecting KCC2 activity is the modulation of its cell 
surface stability and expression. In this thesis, experiments were carried out to 
investigate how direct phosphorylation of KCC2 modulates its cell surface 
stability and co-transport function. Specifically, the aims of this study are: 
 
1)  To demonstrate that KCC2 is phosphorylated on specific residue(s) and 
identify the kinase(s) activities responsible for this phosphorylation. 
2)  To develop a phospho-specific antibody as a molecular tool to examine 
KCC2 phosphorylation.   44
3)  To examine whether phosphorylation of KCC2 modulates its cell 
surface stability and membrane trafficking. 
4)  To examine whether phosphorylation of KCC2 modulates its co-
transport activities.   45
Chapter 2  Methods and Materials 
 
Molecular biology 
 
2.1  Polymerase chain reaction (PCR) 
 
PCR was set up according to manufacturer specifications (Stratagene). 
Typically, reaction mixture in a 50μL reaction contains 5μL 10x PCR reaction 
buffer, 4μL 10mM deoxyribonucleoside triphosphate (dNTP) (Roche, Cat# 
1969064), 2μL each of 10μM sense and anti-sense primers, 5μL plasmid DNA 
template (10ng/μL), 4μL of Pfu turbo polymerase (Stratagene, Cat# 600250-52) 
and 26μL of deionized water. The ingredients were mixed well in a thin-walled 
200μL polypropylene tube and transferred to a thermocycler machine. The 
conditions of thermo cycles depend on application, but are typically: 
 
95
oC for 3min 
95
oC for 30s, 55
oC for 30s and 68
oC for 10min (15-30 cycles) 
68
oC for 5min 
The reaction was stopped by reducing the temperature to 4
oC. 
 
2.2 Bacterial  strains 
 
BL21 [F
-, ompT, hsdSB(rB
-mB
-), gal, dcm] was used in fusion protein induction 
and expression.   46
JM109 [endA1, recA1, gyrA96, thi, hsdR17(rK
-mK
+), relA1, supE44, Δ(lac-
proAB)] was used in plasmid carriage and propagation. 
 
2.3  Preparation of competent cells 
 
Competent cells for electroporation method were prepared according to 
Sambrook and Russell, 2001. First, 50mL of bacteria was inoculated in LB 
broth with appropriate antibiotic which was grown for 16h at 37
oC to 1L LB 
broth with antibiotic. The culture was grown in a shaker for 2h until OD600 
achieved 0.5 and then put in an ice bath for 15min. The bacteria were spun 
down by centrifugation at 1000x g for 15min at 4
oC. The pellet was washed 
with 1L ice-cold deionized H2O followed by 0.5L ice-cold 10% (v/v) glycerol 
and 20mL ice-cold 10% (v/v) glycerol. Finally, the bacteria were spun down 
and resuspended in 10mL GYT medium. The competent cells were kept at -
70
oC in 40μL aliquots. 
 
2.4  Transformation of bacteria with plasmid DNA 
 
Transformation of bacteria (heat shock method) was carried out according to 
Sambrook and Russell, 2001. First, 10μL of transforming materials was mixed 
with 100μL competent cells in a 1.5mL Eppendorf tube for 30min. The tube 
was transferred to a water bath at 42
oC for 45s then quickly transferred to an 
ice bath for 3min. 1mL of LB broth was added to the transformed bacteria and 
the whole tube was transferred to a water bath at 37
oC for 1h. The bacteria 
were then spun down briefly using a benchtop centrifuge, resuspended in   47
100μL of LB broth and spread evenly on an LB agar plate with appropriate 
antibiotic. The LB agar plate was then incubated at 37
oC for 16h or until 
bacterial colonies appeared. 
 
Transformation by electroporation was carried out by first mixing 2μL of 
transforming materials with 100μL electrocompetent cells in a 1.5mL 
Eppendorf tube. The mixture was transferred to a pre-chilled Gene Pulser 
electroporation cuvette (Bio-Rad, Cat# 1652086) and electroporated under the 
transformation protocol provided by the manufacturer. 1mL of LB broth was 
quickly added to the bacteria and transferred to a 1.5mL Eppendorf tube. The 
tube was transferred to a water bath at 37
oC for 1h and spread onto an LB agar 
plate as described above. 
 
2.5 Growth  media 
 
LB broth was made by dissolving 10g of LB broth powder (Sigma, Cat# L3022) 
in 500mL deionized water in a conical glass flask. The dissolved medium was 
autoclaved under 15psi at 121
oC for 30min for sterilization. The LB agar plate 
was made by dissolving 1 package of EZMix LB agar powder (Sigma, Cat# 
L7533) in 500mL deionized water in a glass bottle. The dissolved medium was 
autoclaved similarly and then incubated in a water bath at 55
oC until the 
temperature equilibrated. Appropriate antibiotic was added to the medium, 
mixed well and 20mL aliquots each dispensed into a 100mm diameter Petri 
dish. The plates were allowed to dry, solidified at room temperature, and stored 
at 4
oC.   48
 
2.6  Agarose gel electrophoresis of DNA 
 
A 0.9% w/v agarose gel was made by first mixing 0.45g ultrapure grade 
agarose (Invitrogen, Cat# 15510-027) in 50mL 1x TAE buffer. The mixture 
was boiled in a microwave oven at high power intensity for 2.5min, allowed to 
cool to around 50
oC and 2.5μL ethidium bromide (10mg/mL) added. The 
mixture was poured into a Mini-Sub Cell GT electrophoresis system (Bio-Rad, 
Cat# 170-4406) to set for 30min before use. To perform gel electrophoresis of 
DNA, samples were added with 6x DNA sample buffer and applied to the 
wells of the agarose gel which was placed inside the electrophoresis tank. 
Electrophoresis was carried out by passing 100V across the gel. 
 
2.7 Restriction  digestion of plasmid DNA 
 
Restriction digestion reactions were set up according to manufacturer’s 
instruction (New England Biolabs). Typically, a restriction digestion reaction 
(50μL) was set up by first mixing 5μL 10x reaction buffer (corresponding to a 
particular enzyme), 2μg of plasmid DNA, 5μL restriction enzyme, 0.5μL BSA 
(10mg/mL) and 37.5μL deionized water in a 1.5mL Eppendorf tube. The 
reaction mixture was incubated in a water bath at 37
oC for 1h. The reaction was 
stopped by placing the tube in an ice bath. 
 
2.8  Purification of restriction digested plasmid DNA 
   49
After performing a restriction digestion, the reaction product was analyzed by 
agarose gel electrophoresis. The DNA was visualized under UV light and the 
desired DNA band was cut out with a scalpel. The agarose gel containing DNA 
under purification was weighed and purified using a QIAquick gel purification 
kit (Qiagen, Cat# 28706). 
 
2.9 Ligation 
 
Ligation reactions were set up according to manufacturer’s instruction 
(Invitrogen). Typically, a ligation reaction (10μL) was set up by first mixing 
2μL 5x ligation reaction buffer, 2μL purified, restriction enzyme-digested 
vector, 5μL purified, restriction enzyme-digested DNA inserts and 1μL ligase 
(Invitrogen, Cat# 15224-041) in a thin wall polypropylene tube. The reaction 
mixture was incubated at 16
oC for 12h. The reaction was stopped by placing 
the tube in a -20
oC freezer. 
 
2.10 Site-directed  mutagenesis 
 
Site-directed mutagenesis was carried out first by performing PCR with the 
mutation situated at the primer as described in the QuikChange Site-directed 
mutagenesis kit (Stratagene). After PCR the reaction product was analyzed by 
agarose gel electrophoresis. The amplified DNA product was visualized under 
UV light and cut out with a scalpel. The DNA was purified and digested by 
DpnI restriction enzyme. The product was purified again and ligation was 
performed. The ligation product was then transformed into bacteria by heat-  50
shock or electroporation. Bacterial colonies from transformation were analyzed 
by extracting plasmid DNA from them and sequencing the DNA. 
 
2.11  List of oligonucleotides 
 
Primer name  Primer sequence 
GST-N-S CCAGAATTCAGATGCTCAACAACCTGACGGACTGC 
GST-N-AS CCACTCGAGTCAGCCCATGAAGGTGCCCATGCG 
GST-C-S CCAGAATTCAGCGGGGGGCAGAGAAGGAGTG 
GST-C-AS CCACTCGAGTCAGTTCAAGTTTTCCCACTCCGGCTTC 
His-N-S CCAGGATCCAGATGCTCAACAACCTGACGGACTGC 
His-N-AS CCACTCGAGTCGCCCATGAAGGTGCCCATGCG 
His-C-S CCAGGATCCGAGCGGGGGGCAGAGAAGGAGTG 
His-C-AS CCACTCGAGTCAGTTCAAGTTTTCCCACTCCGGCTTC 
His-112-S CCAGGATCCGATCCGAGGCCTGTCTCTCAGTGCAGC 
His-112-AS CCACTCGAGTCAGGAGTAGATGGTGATGACCTCTCG 
His-C-Δ-S TCGGAGGGGATCAAGGACTTCTTCAG 
His-C-Δ-AS CTGGATCTCCCGTTCCCGCTCGTTCT 
S728A-S GAGGCTATCCGGCGCCT GATGGAGGC 
S728A-AS CTCTGCCCGCTGAGCCTGAGG 
T787A-S AGGAACTTCATCGAACTCGTCCGGGAAACTAC 
T787A-AS CCAAGCCTGATGATCCTCCTTCTGTCGCCAGTTGC 
S940A-S GAATCTCGGGGCGCTATTCGGAGGAAGAATCCAGC 
S940A-AS ATCTGTGATGCTCTGGATCTCCCGTTCC   51
S1034A-S GAAAACTTGAACCAGTCCAACGTGCG 
S1034A-AS CTTCATAGCGAAGAAGTCCTTGATCCCCTCCGAG 
Y1087F-S AACTTCATGGAATTCCTGGAG 
Y1087F-AS TTCATCTCCATTGCGGTTG 
Y1087D-S AACGATATGGAATTCCTGGAG 
Y1087D-AS TTCATCTCCATTGCGGTTG 
 
2.12 DNA  constructs 
 
KCC2-FL: mammalian expression construct of KCC2 in pRK5 vector. The 
KCC2 coding sequence (3351 bp) was obtained from a restriction digestion of 
5E14 clone provided by John Payne using XbaI and HindIII. The DNA insert 
was purified and ligated with pRK5 vector digested with the same enzymes for 
unidirectional cloning (Fig. 2.1). 
GST-N: bacterial expression construct of KCC2 N-tail intracellular domain (aa 
1 to aa 102) in pGEX4T-2 vector (Fig. 2.2). 
GST-C: bacterial expression construct of KCC2 C-tail intracellular domain (aa 
645 to aa 1116) in pGEX4T-2 vector (Fig. 2.2). 
His-N: bacterial expression construct of KCC2 N-tail intracellular domain (aa 
1 to aa 102) in pTrcHis2C vector (Fig. 2.2). 
His-C: bacterial expression construct of KCC2 C-tail intracellular domain (aa 
645 to aa 1116) in pTrcHis2C vector (Fig. 2.2). 
His-112: bacterial expression construct of KCC2 intracellular domain (aa 932 
to aa 1043) in pTrcHis2C vector (Fig. 2.2).   52
 
 
 
 
 
 
NotI
EagI
XbaI
SpeI
BamHI PstI EcoRI SmaI
ATG
EcoRI
EcoRV
HindIII
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SalI XhoI
5’ 3’
Vector: pRK5
Amp+
pCMV
KCC2
TGA
 
Fig. 2.1 Cloning map of KCC2-FL. Coding DNA sequence of KCC2 (3351 
bp) is subcloned into pRK5 vector through XbaI and HindIII restriction sites. 
Expression of KCC2 is driven under mammalian cytomegalo virus promoter 
pCMV. pRK5 vector contains an ampicillin-resistant gene (Amp
+) for selection 
of plasmid after transformation into bacteria.   53
 
 
 
 
pGEX-4T-2
4.9 kb
GST aa 1 to aa 102
GST-N-S
GST-N-AS
Cloning product: GST-N
pTrcHis2C
4.4 kb
6 x (His) aa 932 to aa 1043
His-112-S
His-112-AS
Cloning product: His-112
pGEX-4T-2
4.9 kb
GST aa 645 to aa 1116
GST-C-S
GST-C-AS
Cloning product: GST-C
Cloning product: His-N
pTrcHis2C
4.4 kb
6 x (His) aa 1 to aa 102
His-N-S
His-N-AS
pTrcHis2C
4.4 kb
6 x (His) aa 645 to aa 1116
His-C-S
His-C-AS
Cloning product: His-C
 
Fig. 2.2 Cloning maps of GST-N, GST-C, His-N, His-C and His-112. 
Coding DNA sequences of KCC2 were amplified by corresponding primers 
using PCR and subcloned into pGEX-4T-2 vector to form GST-tagged 
constructs or pTrcHis2C vector to form His-tagged constructs.   54
His-C-Δ: bacterial expression construct of KCC2 C-tail intracellular domain 
with a deletion of aa 932 to aa 1043 in pTrcHis2C vector (Fig. 2.3). 
 
2.13  Small-scale preparation of plasmid DNA from bacteria (mini-prep) 
 
Mini-prep was carried out according to Sambrook and Russell, 2001. Briefly, 
the bacterial colony on an LB agar plate was picked up using a pipette tip and 
transferred to 3mL LB broth with appropriate antibiotic in a 15mL 
polypropylene tube. The culture was grown in a shaker at 200rpm at 37
oC for 
16h. The bacteria were then spun down in a benchtop centrifuge at top speed. 
Extraction of plasmid DNA was performed by first resuspending bacteria in a 
1.5mL Eppendorf tube in 100μL of solution containing 50mM glucose, 25mM 
Tris-Cl and 10mM EDTA (pH8) (Solution I). To the resuspension, 200μL of 
solution containing 0.2N NaOH and 1% w/v sodium dodecyl sulphate (SDS) 
(Solution II) was added and the mixture was inverted 5 times until it became 
sticky. Next, 150μL of solution containing 3M potassium acetate and 11.5% 
glacial acetic acid (Solution III) was added and mixed quickly. The mixture 
was then placed in an ice bath for 3min and spun down in a benchtop 
centrifuge at top speed for 5min at 4
oC. Supernatant after centrifugation was 
collected in a new 1.5mL Eppendorf tube and 450μL of phenol/chloroform 
mixture (1:1 v/v) was added and mixed well. The mixture was separated by 
centrifuge at top speed for 2min at 4
oC, and the upper layer transferred to a 
new 1.5mL tube. To the solution in the new tube, 900μL of 95% ethanol was 
added, mixed and allowed to stand for 2min at room temperature. Plasmid 
DNA was then collected as a pellet by centrifugation at top speed for 5min at    55
 
 
 
 
 
 
TCG GAG GGG ATC AAG GAC TTC TTC AG
CTG GAT CTC CCG TTC CCG CTC GTT CT
Sense primer (His-C-Δ-S):
Antisense primer (His-C-Δ-AS):
pTrcHis2C
4.4 kb
6 x (His) aa 645 to aa 1116
His- C-Δ-S
His- C-Δ-AS
Cloning product: His-C-Δ
pTrcHis2C
4.4 kb
6 x (His)
Re-ligate
aa 932 aa 1043
Original clone: His-C
 
 
Fig. 2.3 Cloning of His-C-Δ. Polymerase chain reaction was performed on the 
original template His-C with primers His-C-Δ-S and His-C-Δ-AS. The product 
was re-ligated to form a plasmid that expresses C-tail of KCC2 with a deletion 
from aa 932 to aa 1043.   56
4
oC. The DNA pellet was then washed using 1mL of 70% ethanol, dried and 
resuspended in 50μL deionized water. 
 
2.14  Large-scale preparation of plasmid DNA from bacteria (maxi-prep) 
by caesium chloride 
 
Maxi-prep was carried out according to Sambrook and Russell, 2001. A 250mL 
bacterial culture in LB broth in appropriate antibiotic was first grown for 16h. 
Bacteria were then spun down by centrifuge at 1000x g for 15min. After 
removal of supernatant, bacteria were resuspended in 10mL of Solution I. To 
the resuspension, 20mL of Solution II was added and the mixture inverted 5 
times until it became sticky. The mixture was then put in an ice bath for 5min. 
After that, 15mL of Solution III was added and mixed quickly. The mixture 
was then put in an ice bath again for 5min. The debris was removed by 
centrifugation at 3000x g for 20min, while the supernatant was added to an 
equal volume of isopropanol and mixed well. Centrifugation at 3000x g was 
performed and a DNA pellet was obtained. The pellet was then dissolved in 
10mL of deionized water. DNA was precipitated again by adding 1mL of 5M 
ammonium acetate and 25mL of 95% ethanol. The precipitated DNA was 
collected by centrifugation at 3000x g for 10min. The DNA pellet was then 
dissolved again by deionized water. Caesium chloride was added to the 
solution such that caesium chloride concentration was 1g/mL. To this 
resuspension, 100μL ethidium bromide solution (10mg/mL) was added. The 
solution was then dispensed into Quick-seal polyallomer tubes (Beckman, Cat# 
358980) and subject to ultracentrifugation at 100,000rpm at 22
oC for 16h. After   57
centrifugation, 2 bands of DNA stained with red ethidium bromide were visible 
as they appeared at the middle of the height of the centrifuge tube. These bands 
were removed using a needle and syringe puncturing the side of the tube. 
Typically 2mL of DNA solution stained with ethidium bromide was extracted. 
To purify, 4mL of water-saturated butanol was mixed with the DNA and the 
mixture allowed to stand for 5min. Two immiscible layers of liquid were 
observed and ethidium bromide was removed in the upper butanol layer. This 
extraction process was repeated 3 times until no red color was observed in the 
bottom aqueous layer. DNA was then precipitated by adding 8mL of 95% 
ethanol. Centrifugation at 3000x g for 15min was performed and a DNA pellet 
was obtained. The pellet was then resuspended in 1mL deionized water. 
 
Cell biology 
 
2.15  Cell line culture 
 
A HEK-293 cell line was purchased from American Type Culture Collection 
(ATCC). Cells were maintained in Dulbecco’s Modified Eagle Medium with 
F12 supplement (DMEM/F12, 1:1) (Gibco, Cat# 11330) with 10% fetal bovine 
serum (FBS) and penicillin/streptomycin (diluted 100 times from 10000 
unit/mL penicillin G sodium and 10000 μg/mL streptomycin sulphate in 0.85% 
saline, Gibco, Cat# 15140-122) in a 100mm culture dish. Cell cultures were 
kept in a humidified incubator at 37
oC with 5% CO2 supply. When cultures 
achieved 70% confluency, cells were removed and passed on to new dishes. 
Medium was removed by aspiration and cells then washed in 1x phosphate-  58
buffered saline (PBS). After PBS was removed by aspiration, 1mL of 0.05% 
trypsin-EDTA solution (Gibco, Cat# 15400-054) was added to the cells and the 
dish put back into an incubator for 1min. Cells were then removed from the 
dish by adding 10mL growth medium. The cell suspension was pipetted up and 
down 20 times to ensure that the cells were efficiently dissociated. 2mL of the 
suspension was then transferred to a new culture dish with 8mL of new growth 
medium. 
 
2.16  Transient transfection of HEK-293 cells 
 
Transfection of HEK-293 cells by electroporation was carried out according to 
Sambrook and Russell, 2001. First, cells were removed from the 100mm dish 
by washing briefly in 1x PBS and 1mL 0.05% trypsin-EDTA was then added 
to the dish. The dish was incubated at 37
oC for 1min and 10mL growth 
medium was added to resuspend cells. After dissociation of cells by pipetting 
up and down, cells were spun down by centrifugation at 1000x g for 5min. 
Medium was then removed and 200µL of Opti-MEM-reduced serum medium 
(Gibco, Cat# 11058-021) was added to resuspend cells. To 100µL of the 
resuspended cells, 3µg of plasmid DNA was added and transferred to a Gene 
Pulser electroporation cuvette (Bio-Rad, Cat #. 1652086). The cells were 
electroporated using a pre-set program in the Gene Pulser XCell 
electroporation machine (Bio-Rad), then transferred back to a 60mm culture 
dish with 5mL of growth medium. 
 
2.17  List of antibodies   59
 
Monoclonal mouse anti-KCC2 IgG, clone N1/12 (UC Davis NeuroMab facility, 
Cat# 75-013) 
Polyclonal rabbit anti-KCC2 IgG (Millipore, Cat# 07-432) 
Polyclonal rabbit anti-KCC2 phospho-Ser
940 IgG, p-S940 (PhosphoSolutions, 
custom-made) (See also section 4.1) 
Monoclonal mouse anti-tubulin IgG (Abcam, Cat#ab7291) 
Polyclonal donkey HRP-conjugated anti-rabbit IgG (Amersham, Cat# NA934V) 
Polyclonal goat HRP-conjugated anti-mouse IgG (Pierce, Cat# 1858413) 
Fluorescein-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch, 
Cat# 715-095-150) 
Rhodamine-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, 
Cat# 711-025-152) 
 
2.18 Immunofluorescence  staining 
 
Staining of proteins with fluorescent antibody was performed as previously 
described (Kittler et al., 2000). Cells grown on 12mm glass cover slips were 
transferred to a 24-well culture plate with 300µL 4% paraformaldehyde/4% 
sucrose solution for fixation for 15min. Cells were then washed 3 times in 1x 
PBS and incubated with 5% milk solution in 0.2% triton (blocking solution) for 
10min. Primary antibody was added to the cells in the blocking solution for 1h, 
the cells then washed 5 times in 1x PBS, and secondary antibody added to the 
cells in the blocking solution for 45min. Finally the cells were washed in 1x 
PBS and mounted on glass slides.   60
 
2.19 Confocal  microscopy 
 
A mounted specimen was viewed using a confocal laser-scanning microscope 
with a 60x oil objective. Green fluorescence protein (GFP) and fluorescein 
isothiocyanate (FITC) were excited by a laser of wavelength 488nm and signal 
received by emission filter HQ530/60. Tetramethyl rhodamine isothiocyanate 
(TRITC) was excited by laser of wavelength 543nm and signal received by 
emission filter HQ590/70. Acquisition of confocal images was carried out 
using Laser Sharp 2000 software from Bio-Rad. To ensure no spectral bleed 
through, laser scans for green and red fluorescence signal were sequentially 
collected. Under such conditions the green fluorescence signal during red laser 
illumination (and vice versa) was negligible. Pseudo color (green for GFP and 
FITC, red for TRITC) was assigned automatically by the software after each 
laser scan was acquired. 
 
Biochemistry 
 
2.20  Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Acrylamide gel was set according to Sambrook and Russell, 2001 by first 
mixing 1.5M Tris-Cl (pH8.8), 30% acrylamide/bis solution, 29:1 (Bio-Rad, 
Cat# 161-0156), 10% ammonium persulphate (APS), 10% SDS, N, N, N’, N’-
tetramethylethylenediamine (TEMED) and deionized water and poured into the   61
Mini PROTEAN 3 system gel casting stand (Bio-Rad) according to 
manufacturer’s instructions. 70% ethanol was added slowly on top of the gel 
layer to form a horizontal straight boundary for the gel. This served as the 
resolving gel. After 30min, the ethanol was washed in deionized water, dried 
and a second layer of acrylamide gel (stacking gel) made by mixing 1.0M Tris-
Cl (pH6.8), 30% acrylamide/bis solution, 29:1, 10% APS, 10% SDS, TEMED 
and deionized water. The stacking gel was laid on top of the resolving gel and a 
plastic comb placed on top to form wells in the stacking gel for holding protein 
samples. After 30min, the gel was set and assembled into the Mini PROTEAN 
3 system gel running tank (Bio-Rad) according to manufacturer’s instructions. 
Gel running buffer was added to the tank and protein samples were loaded into 
the wells of the gel. Protein samples were separated by electrophoresis under 
160V for 1h. 
 
2.21  Electrotransfer of SDS-PAGE gels 
 
Electrotransfer of SDS-PAGE gels was set up according to manufacturer’s 
instructions (Bio-Rad). Acrylamide gel was taken out from the gel tank after 
electrophoresis. It was then transferred to a Mini Trans-Blot cell unit (Bio-Rad) 
in a sandwich of filter paper and sponge fiber pads on both sides. A 
nitrocellulose membrane was also placed directly next to the gel. The cassette 
was set according to manufacturer instructions and electrophoresis was carried 
out in a constant current at 50mA for 16h. 
 
2.22 Western  blotting   62
 
Western blotting was carried out essentially as described in McDonald et al., 
1998. After electrotransfer, the nitrocellulose membrane was removed from the 
tank. It was washed briefly with 0.1% (w/v) ponceau S in 5% acetic acid. The 
ponceau S solution was washed with deionized water and the positions of the 
molecular markers marked using a pencil. The membrane was then washed 
briefly with 1x Tris-buffered saline with 0.1% Tween (TBS-T) and incubated 
in 5% milk in TBS-T for 1h for blocking. Primary antibody was added with 
proper dilution to 5% milk in TBS-T for 2h and the membrane then washed 3 
times for 10min each wash with TBS-T. Secondary antibody was then added in 
5% milk in TBS-T to incubate the membrane for 1h. Again, the membrane was 
washed 3 times for 10min with TBS-T. Finally, the membrane was dried 
briefly and 1mL of VisiGlo HRP Plus chemiluminescent substrate (Amresco, 
Cat# N219) was applied to the membrane for 1min for developing 
chemiluminescence. Excess fluid was dripped off from the membrane and the 
membrane visualized using a FujiFilm LAS-3000 chemiluminescence detection 
unit. 
 
2.23  Fusion protein purification 
 
Purification of GST-fusion protein was described previously (Moss et al., 
1992). First, 20mL of bacterial culture was grown for 16h then transferred to 
1L LB broth with appropriate antibiotic. The culture was allowed to grow at 
37
oC with constant shaking at 200rpm. When the OD600 of the culture achieved 
0.5, 47.6mg isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma, Cat# I6758)   63
was added directly to the culture (0.2mM IPTG induction) to allow induction 
of protein expression. The culture was allowed to grow at 37
oC while shaken 
for 3h. To harvest the bacteria, the culture was transferred to a 1L bottle and 
centrifuged at 1000x g for 20min at 4
oC. The supernatant was removed and the 
bacterial pellet resuspended in 10mL of buffer (Buffer A) containing 50mM 
Tris-Cl (pH8.0), 25% sucrose and 10mM EDTA. The bacteria were then spun 
down by centrifugation at 1000x g for 15min and resuspended in 10mL of lysis 
buffer (Buffer B) containing 1% Triton X-100, 1mM EDTA, 10mM Tris-Cl 
(pH7.4) and protease inhibitors. The lysate was stored at -20
oC for 16h. The 
next day, bacterial lysate was thawed and sonication was applied to the lysate 
to assist the breakdown of the bacterial cell wall. To the lysate, 25mL of a 
solution (Buffer C) containing 20mM HEPES (pH7.6), 100mM KCl, 0.2mM 
EDTA, 20% glycerol and protease inhibitors was added. The lysate was then 
spun at 75000x g for 30min at 4
oC to get rid of insoluble materials. 80mg of 
glutathione-agarose beads (Sigma, G4510) were soaked in Buffer C for 10min 
at 4
oC and washed 3 times with Buffer C. The beads were incubated for 2h 
with the supernatant after centrifugation on a rotating wheel at 4
oC then spun 
down by centrifugation at 1000x g and washed twice with Buffer C. Finally, 
the beads were incubated with 2mL of 70mM glutathione (pH7.4) in PBS to 
elute the fusion protein. The fusion protein was dialyzed with a solution 
containing 20mM Tris-Cl (pH7.4) and 2mM EDTA for 16h. 
 
His-tag fusion protein was purified from 50mL bacterial culture as described in 
the ProBond purification system manual (Invitrogen, Cat# K850-01). Briefly, a 
bacterial culture (2mL) grown for 16h was transferred to 50mL LB broth. The   64
culture was kept at 37
oC for around 2h while being shaken until its OD600 
achieved 0.5. 0.2mM IPTG was added to the culture and fusion protein induced 
at 37
oC for 3h in shaker. Bacteria were then collected by centrifugation at 
1000x  g for 5min. To the bacterial pellet, 8mL of guanidium lysis buffer 
containing 6M guanidine HCl, 20mM NaPO4 (pH7.8) and 500mM NaCl was 
added. The lysate was placed on a rotating wheel for 5min at room temperature 
and sonication was performed to assure thorough cell lysis. The cellular debris 
was then removed by centrifugation at 3000x g for 15min. To 8mL of lysate, 
2mL of ProBond resin in 1:1 slurry (Invitrogen, Cat# 46-0019), which was 
washed by water and resuspended in denaturing binding buffer, was added. The 
resin was allowed to bind to fusion proteins in the lysate for 30min at room 
temperature on a rotating wheel. After that, the resin was collected by 
centrifugation at 1000x g and washed 2 times by 4mL denaturing binding 
buffer (pH6.0). The resin was then washed twice by 4mL denaturing wash 
buffer (pH5.3). The fusion protein was eluted from the resin by 5mL 
denaturing elution buffer. Finally, fusion protein was dialyzed by 1L of 
solution containing 10mM Tris-Cl (pH8.0), 0.1% Triton X-100 at 4
oC for 16h 
to remove urea. 
 
2.24  In vitro kinase assay 
 
In vitro kinase assay was performed according to procedure described in Moss 
et al., 1992. Purified fusion protein was incubated with buffer containing 
20mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH7.5), 
10mM MgCl2, 50nM phorbol 12, 13-dibutyrate (PDBu), 0.2mM adenosine   65
triphosphate (ATP), 10µCi of [γ-
32P]ATP and 5µL of purified protein kinase C 
(PKC, 10ng/μL) (Millipore, Cat# 14-115) in a 50µL reaction. The reaction 
mixture was incubated in a water bath at 30
oC for 30min and the reaction 
terminated by adding 50µL of 2x SDS-PAGE sample buffer. Phosphorylation 
signal of protein (represented by 
32P  β-radiation) was captured using a 
phospho-imager screen (Bio-Rad, Cat# 1707843) and visualized using a 
molecular imager FX machine (Bio-Rad). 
 
The stoichiometry of phospho-proteins was calculated by the following 
equations: 
X=specific count reading from scintillation counter by 1μL of [γ-
32P]ATP 
(CPM) 
Y=amount of ATP in 1μL of [γ-
32P]ATP (mole) 
Therefore, count/mole of ATP (CPM/mole)=X/Y 
Z=specific count reading from scintillation counter by phosphorylated protein 
Therefore, amount of phospho-proteins (mole)=Z/(X/Y) 
 
2.25  Phospho-peptide mapping and phospho-amino acid analysis 
 
Procedures of phospho-peptide mapping and phospho-amino acid analysis 
were modified from Moss et al., 1992. After SDS-PAGE and phospho-imager 
analysis, protein labeled with radioactive isotope was excised from the 
acrylamide gel with a scalpel. The gel was washed 3 times for 30min each 
wash using destaining buffer. It was then washed twice for 30min each wash 
using 50% (v/v) methanol. The gel was dried briefly with filter paper and   66
incubated with 1mL of trypsin (1mg/mL) in 50mM NH4HCO3 at 37
oC for 16h. 
The next day, the supernatant was collected and 0.5mL of trypsin solution was 
added at 37
oC for 2h to extract the residual phospho-protein from the gel. The 
trypsin solution was combined and lyophilized under centrifugation in a 
vacuum. The lyophilized product was dissolved in 10µL of deionized water. 
This trypsinized protein was applied to a thin layer chromatography (TLC) 
plate (Selecto Scientific, Cat# 10028) together with 1μL each of phenol red 
(10mg/mL) and basic fuchsin (10mg/mL). The TLC plate was pre-wet with 
TLC electrophoresis buffer and then subjected to electrophoresis under 500V 
for 2.5h. After electrophoresis the TLC plate was dried, and a liquid 
chromatography was performed in a vertical manner. Finally the TLC plate 
was dried and phospho-peptide was detected using a phospho-imager. 
 
Phospho-amino acid analysis was carried out using 6N HCl to hydrolyzed 
tryptic peptides for 1h after they were recovered from the gel as described 
above. The hydrolyzed product was then lyophilized and dissolved in 10µL of 
deionized water similarly. When the sample was applied to the TLC plate, 
phospho-amino acid standards (phospho-serine, -threonine and -tyrosine, 
10mg/mL) and phenol red (10mg/mL) were also applied and separated by 
electrophoresis at 500V for 1.5h. After electrophoresis the plate was dried, 
amino acid was stained briefly using 1% (w/v) ninhydrin solution at 60
oC and 
the TLC plate was quickly dried again. The composition of phospho-amino 
acid was then analyzed using a phosphor-imager. 
 
2.26  In vitro phosphatase assay   67
 
In vitro phosphatase assay was performed according to Terunuma et al., 2004. 
Purified fusion protein was first phosphorylated using an in vitro kinase assay 
with ATP in the presence of Ni
2+ resin (for His-tag fusion proteins) or 
glutathione-coated agarose beads (for GST-fusion proteins). The labeled 
protein was then briefly spun down using centrifugation, washed with buffer 
containing 50mM Tris-Cl (pH7.6) and 3µL of purified phosphatase was added 
to the reaction mixture and incubated at 30
oC for 15min. The fusion protein 
was briefly spun down using centrifugation, the reaction stopped by adding 
20µL of sample buffer and the fusion protein then analyzed using SDS-PAGE. 
 
2.27 Whole-cell  metabolic  labeling 
 
Whole-cell metabolic labeling experiments were carried essentially as 
described previously (Moss et al., 1992). Cells were washed twice with pre-
warmed phosphate-free DMEM (Invitrogen, Cat# 11971) and incubated at 
37
oC in phosphate-free medium for 30min. 1mCi of 
32P in orthophosphoric 
acid (H3
32PO4) (PerkinElmer, Cat# NEX053 P062304W) was then added to the 
medium and the cells incubated at 37
oC for 4h. 
 
2.28 Biotinylation  assay 
 
Biotinylation was carried out as described previously (Fairfax et al., 2004). 
Cells were first washed twice with 1xPBS with 50mM MgCl2 and 100mM 
CaCl2 (PBS-CM). The cells were then incubated with 2mL of PBS-CM   68
containing 2mg of EZ-link Sulfo-NHS-SS-biotin (Pierce, Cat# 21331B) for 
30min. After that, cells were washed 3 times with PBS-CM containing glycine 
and bovine serum albumin (BSA) (quench buffer). Lastly, cells were washed 
with 1xPBS and lysed with lysis buffer. The cell lysate was spun in a benchtop 
centrifuge at top speed for 10min to get rid of insoluble materials. To the 
supernatant, 40μL of 1:1 slurry of UltraLink immobilized Neutravidin beads 
(Pierce, Cat# 53150) in lysis buffer was added. The mixture was incubated at 
4
oC on a rotating wheel for 2h. The beads were spun down using centrifugation 
at 1000x g for 2min, washed twice with lysis buffer with 0.5M NaCl and once 
with lysis buffer alone. Lysis buffer was removed after centrifugation and 
20μL of sample buffer was added to the beads. The sample was then analyzed 
using SDS-PAGE. 
 
2.29 Endocytosis  assay 
 
Hippocampal neurons were labeled with 1mg/mL EZ-link Sulfo-NHS-SS-
Biotin as described above, washed with quench buffer and returned to 37
oC 
incubator for endocytosis to occur for different durations up to 20min in the 
presence of culture medium containing 1μM leupeptin. Cells were then quickly 
cooled on ice and cell surface biotin was cleaved with cleavage buffer (quench 
buffer containing 50mM glutathione) for 15min on ice. The internalized biotin-
labeled proteins were pulled down with UltraLink immobilized Neutravidin 
beads and analyzed by SDS-PAGE followed by immunoblotting as described 
above. 
   69
2.30 Protein  assay 
 
Protein assay was performed according to manufacturer’s instruction (Bio-Rad). 
The protein sample was diluted 20 times with deionized water. To 100μL of 
diluted sample, 100μL of BCA solution (a combination of 2.5mL buffer A, 
2.4mL buffer B and 0.1mL buffer C from a Micro BCA protein assay kit from 
Pierce, Cat# 23235) was added. A protein standard curve was made by diluting 
2mg/mL BSA solution in a series dilution from 100μg/mL to 10μg/mL. 100μL 
of BCA solution was added to 100μL of each of the BSA protein standards. 
The standard curve and protein sample were incubated at 60
oC in a 96-well 
plate for 1h for colorimetric development. After that, OD570 of each sample 
was measured using a microplate reader 680 (Bio-Rad). The protein 
concentration of each sample was calculated from the protein standard curve. 
 
2.31 Immunoprecipitation 
 
Immunoprecipitation of proteins was performed as described previously 
(Kittler et al., 2000). Cells were lyzed in 1mL lysis buffer, collected in a 1.5mL 
polypropylene tube and spun in a benchtop centrifuge at top speed at 4
oC for 
10min. To the supernatant, 40μL of 1:1 slurry of protein A sepharose CL-4B 
beads (Amersham, Cat# 17-0780-01) in 1xPBS was added and the mixture was 
incubated at 4
oC on a rotating wheel for 2h. The beads were spun down at 
1000x g for 2min and washed twice with lysis buffer containing 0.5M NaCl 
and once with lysis buffer alone. Lysis buffer was removed after centrifugation   70
and 20μL of sample buffer was added to the beads. The sample was then 
analyzed using SDS-PAGE. 
 
2.32 
86Rb
+ influx assay 
 
HEK-293 cells were transfected with KCC2-FL WT or a series of mutants 
including S728A, T787A, S940A, S1034A and double mutants S940/1034A 
and S728/940A. One day after transfection cells were treated with 2µM 
bumetanide and 100µM ouabain to inhibit Na
+-K
+-2Cl
- co-transporter and Na
+-
K
+-ATPase respectively. 
86Rb
+ accumulation was allowed to proceed over a 3-
5min time course. Cells were then washed extensively with PBS to remove 
extracellular 
86Rb
+ and cells lyzed to measure radioactivity using a scintillation 
counter. Experiments were repeated with 100µM furosemide to inhibit KCC2 
activity and the difference between samples with or without furosemide 
treatment was recorded as furosemide-sensitive 
86Rb
+ influx, an indicator of 
KCC2 activity. As a negative control vector-transfected cells showed no 
86Rb
+ 
accumulation. This experiment was performed by Jeff Williams in 
collaboration with the laboratory of Dr. John Payne at UC Davis. 
 
2.33 Hydrophobicity  plot 
 
The amino acid sequence was analyzed by the software provided on the 
website http://www.vivo.colostate.edu/molkit/hydropathy/index.html using 
Kyte-Doolittle scale and window size of 20. 
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2.34 Statistics 
 
Standard error of the mean (SEM) was calculated using Excel from quantified 
data. Student’s t-test was then performed using GraphPad Software for 
statistical significance. 
 
2.35  List of buffers, drugs and chemicals 
 
The recipes of commonly used buffers, and the solvent and concentration of 
drugs and chemicals described in this thesis are: 
 
GYT medium 
10% (v/v) Glycerol 
0.125% (w/v) Yeast extracts 
0.25% (w/v) Tryptone 
 
TAE 
40mM Tris-acetate 
1mM EDTA (pH8.0) 
 
DNA sample buffer (6x) 
30% (v/v) Glycerol 
0.25% (w/v) Xylene cyanol 
 
Buffers for plasmid extraction from bacteria:   72
1) Solution I 
50mM Glucose 
25mM Tris-Cl (pH8.0) 
10mM EDTA (pH8.0) 
 
2) Solution II 
0.2N NaOH 
1% (w/v) SDS 
 
3) Solution III 
5M Potassium acetate 
11.5% (v/v) Acetic acid 
 
Buffers for GST-fusion protein purification: 
1) Buffer A 
50mM Tris-Cl (pH8.0) 
25% Sucrose 
10mM EDTA 
 
2) Buffer B 
10mM Tris-Cl (pH7.4) 
1mM EDTA 
1% Triton X-100 
1mM DTT 
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3) Buffer C 
20mM HEPES-NaOH (pH7.6) 
100mM KCl 
0.2mM EDTA 
20% Glycerol 
 
Buffers for His-tagged fusion protein purification in denaturing condition: 
Guanidinium lysis buffer 
6M Guanidine HCl 
20mM NaPO4, pH7.8 
500mM NaCl 
 
Denaturing binding buffer 
8M Urea 
20mM NaPO4, pH7.8 
500mM NaCl 
 
Denaturing wash buffer 
8M Urea 
20mM NaPO4, pH6.0 
500mM NaCl 
 
Denaturing elution buffer 
8M Urea 
20mM NaPO4, pH4.0   74
500mM NaCl 
 
Cell lysis buffer (2x) 
20mM NaPO4, pH7.4 
10mM EDTA 
10mM EGTA 
200mM NaCl 
20mM Sodium pyrophosphate 
50mM NaF 
4% Triton X-100 
1% Deoxycholate 
2mM Sodium orthovanadate 
 
Coomassie blue staining solution 
30% (v/v) Methanol 
10% (v/v) Acetic acid 
0.25% (w/v) Brilliant blue G 
 
Destaining solution 
30% (v/v) Methanol 
10% (v/v) Acetic acid 
 
SDS-PAGE running buffer 
25mM Tris 
250mM Glycine   75
0.1% (w/v) SDS 
 
SDS-PAGE transfer buffer 
48mM Tris 
39mM Glycine 
0.0375% SDS 
 
Phosphate-buffered saline 
137mM NaCl 
2.7mM KCl 
10mM Na2HPO4 
2mM KH2PO4 
 
Tris-buffered saline 
8g of NaCl, 0.2g of KCl and 3g of Tris base were dissolved in 800mL 
deionized H2O. The pH value of the solution was adjusted to 7.4 by slowly 
adding HCl and then more H2O was added to make the solution up to 1L. 
 
SDS-PAGE sample buffer (2x) 
100mM Tris-Cl (pH6.8) 
4% (w/v) SDS 
0.2% Bromophenol blue 
20% Glycerol 
Freshly add 100mM β-mercaptoethanol into 1x buffer before use 
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TLC electrophoresis buffer 
17.4% (v/v) Acetic acid 
0.92% (v/v) Pyridine 
 
TLC chromatography buffer 
7.5% (v/v) Acetic acid 
37.5% (v/v) Pyridine 
25% (v/v) 1-Butanol 
 
PBS-CM 
PBS with 1mM CaCl2 and 0.5mM MgCl2 
 
Quench buffer for biotinylation 
PBS-CM with 50mM glycine and 0.1% (w/v) BSA 
Phorbol 12,13-dibutyrate (PDBu) (Calbiochem, Cat# 524390) 
0.5mM stock was dissolved in DMSO, stored at -20
oC and used in 500nM 
 
GF109203X (GFX) (Tocris, Cat# 0741) 
10mM stock was dissolved in DMSO, stored at -20
oC and used in 10μM 
 
Calphostin C (CalC) (Calbiochem, Cat# 208725) 
100μM stock was dissolved in DMSO, stored at -20
oC and used in 100nM 
 
Cyclosporin A (CsA) (Calbiochem, Cat# 239835) 
20mM stock was dissolved in DMSO, stored at -20
oC and used in 20μM   77
 
Okadaic acid (OA) (Calbiochem, Cat# 459620) 
100μM stock was dissolved in DMSO, stored at -20
oC and used in 100nM 
 
Sodium pervanadate (Na3VO4), peroxide of sodium orthovanadate (Sigma, 
Cat# S6508) 
30mM sodium orthovanadate activated by 0.18% H2O2 for 15min at room 
temperature in the dark, freshly made and used in 100μM 
 
PP2, a specific Src family kinase inhibitor (Calbiochem, Cat# 529573) 
10mM stock was dissolved in DMSO, stored at -20
oC and used in 10μM 
 
PP3, a specific EGFR kinase inhibitor (Calbiochem, Cat# 529574) 
10mM stock was dissolved in DMSO, stored at -20
oC and used in 10μM   78
Chapter  3  Direct phosphorylation of KCC2 by PKC and tyrosine 
kinase 
 
Introduction 
 
It has been previously established that KCC2 activity is regulated by activators 
of protein kinase C (PKC), WNK family kinase 3 (WNK3), brain type creatine 
kinase (CKB), as well as inhibitors of serine/threonine protein phosphatases 
PP1 and PP2A (Kelsch et al., 2001; Song et al., 2002; Rivera et al., 2004; 
Kahle et al., 2005; Bergeron et al., 2006; Inoue et al., 2006), suggesting that 
phosphorylation of this protein may be the molecular mechanism underlying 
these observations. However, currently there is no evidence that KCC2 is in 
fact a phospho-protein (Bergeron et al., 2006). From a perspective of consensus 
sequence comparison (Payne et al., 1996), it has been shown that there are 
several putative PKC phosphorylation sites (R/K)(X)1-4(S/T)(X)1-3(R/K)(where 
X is any amino acid)(Kennelly and Krebs, 1991) and a protein tyrosine kinase 
(PTK) phosphorylation site YXXØ (where X is any amino acid and Ø is a 
hydrophobic residue)(Ding et al., 2003) within the intracellular domains of the 
KCC2 sequence. Among these sites, Ser
728, Thr
787 and Ser
1034 co-exist in other 
KCC members while Thr
34 and Ser
940 are unique to KCC2. On the other hand, 
the putative PTK phosphorylation site Tyr
1087 also exists in other KCC 
isoforms (Strange et al., 2000) (Fig. 3.1). A list of the putative phosphorylation 
sites on KCC2 sequence can be found in Figure 3.1. 
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Fig. 3.1 Sequence comparison of KCC members and the locations of 
possible phosphorylation sites on KCC2. Putative PKC phosphorylation sites 
are labeled as S for serine and T for threonine. Putative PTK phosphorylation 
sites are labeled as Y for tyrosine. The positions of these sites in the KCC2 
sequence are denoted by numbers. Phosphorylation sites co-existing in other 
KCC members are indicated by arrows.   80
Protein kinases are enzymes responsible for phosphorylation reactions that 
transfer phosphate groups from adenosine triphosphate (ATP) to amino acid 
residues in proteins such as serine, threonine or tyrosine. PKC belongs to a 
serine/threonine-specific kinase that plays a major role in various cellular 
mechanisms including cell proliferation, differentiation, protein degradation 
and intracellular trafficking (Connolly et al., 1999; Brandon et al., 2000; 
Nakashima, 2002). In mammalian neurons, expression of PKC is abundant and 
its activity is under tight regulation (Pascale et al., 2007). PKC can be 
classified as conventional (classical), unconventional (novel) or atypical 
(Becker and Hannun, 2005). Different classes of PKC have different 
requirements for activation. Conventional PKC is activated by calcium ions, 
diacylglycerol (DAG) and phospholipids. Unconventional PKC is activated by 
DAG but calcium is not required. Atypical PKC requires neither calcium nor 
DAG for activation. PTKs are another big class of kinases that catalyze the 
addition of phosphate into a tyrosine moiety. They consists of two types of 
enzymes: receptor tyrosine kinases (RTKs) and non-receptor protein tyrosine 
kinases (Hubbard and Till, 2000). RTKs typically consist of an extracellular 
ligand binding domain, transmembrane domain and intracellular catalytic 
domain which carries out a kinase reaction (Ottensmeyer et al., 2000). Upon 
ligand binding, dimerization of receptors occurs which leads to 
autophosphorylation of receptors. This conformational change then increases 
the accessibility of substrate and ATP to the catalytic domain such that 
phosphorylation is carried out. Among the non-receptor protein tyrosine 
kinases, v-Src is one of the first identified (Collett and Erikson, 1978). It was 
later classified as a member of Src family tyrosine kinases which consists of   81
Src, Fyn, Fgr, Lyn, Hck, Blk, Lck, Yes and Yrk. Tyrosine kinases are involved 
in many signal transduction pathways and are important for cellular 
differentiation, cell death and neurite outgrowth (Rogers et al., 1994; Wu et al., 
1999). 
 
The role of phosphorylation in regulating inhibitory transmission in the central 
nervous system is well documented (Moss and Smart, 1996; Belelli et al., 
2006). The GABAA receptor is the main site for generating inhibitory current 
and has been shown to be phosphorylated by PKC and Src among many 
kinases (Boxall, 2000; Brandon et al., 2000; Brandon et al., 2001; Song and 
Messing, 2005). Since KCC2 controls the Cl
- gradient across the neuronal 
membrane and is critical in dictating the GABAergic response in mature 
neurons (Rivera et al., 1999), the roles that PKC and Src are playing in the 
regulation of KCC2 is of crucial importance in the research on KCC2 currently. 
 
The use of recombinant protein systems in investigating phosphorylation of 
membrane proteins is popular (Krishek et al., 1994; Raymond et al., 1994; 
Song and Kaczmarek, 2006); for example, fusion proteins have been used 
extensively to investigate the phosphorylation of GABAA receptor subunits and 
to identify their phosphorylation sites (Moss et al., 1992; McDonald et al., 
1998; Brandon et al., 2000; Houston et al., 2007). To initiate the study of 
KCC2 phosphorylation, fusion proteins of KCC2 intracellular domains were 
used coupled with an in vitro kinase assay. Specific sites for phosphorylation 
were also identified. To confirm the in vitro studies recombinant KCC2 
proteins were expressed in HEK-293 cells.   82
 
In this chapter, the role of PKC and PTK in the phosphorylation of KCC2 was 
determined. This serves as the background for the study of phospho-dependent 
modulation of KCC2 since the identity of kinases and the kinetics of 
phosphorylation remain unknown. The specific aims of this chapter are: 
 
1)  To show that PKC phosphorylates KCC2 directly in vitro. 
2)  To identify the residues of KCC2 responsible for phosphorylation by 
PKC. 
3)  To show that KCC2 expressed in HEK-293 cells and endogenous 
KCC2 in cultured hippocampal neurons is phosphorylated by PKC. 
4)  To show that KCC2 is phosphorylated by Src. 
 
Results 
 
3.1  Expression of GST-tag and His-tag fusion proteins encoding the N-
tail and C-tail of KCC2 
 
The coding sequences of N-tail (residues 1-102) and C-tail (residues 645-1116) 
of KCC2 were amplified and subcloned into pGEX4T-2 (McDonald and Moss, 
1994) to generate GST-tagged fusion protein in bacteria (Fig. 3.2). After 
induction with IPTG, bacterial lysates were resolved by SDS-PAGE and the 
gel stained with Coomassie blue to confirm the expression of fusion proteins. 
However, the attempt to purify GST-tagged fusion protein of C-tail of KCC2 
was unsuccessful, mainly because the protein was expressed in the insoluble    83
 
 
 
 
(His)6 or GST
(His)6 or GST
1 2 3 4 5 6 7 8 9 10 11 12
NH2
COOH
KEY: N-linked oligosaccharides
1 Transmembrane domains
Extracellular
Intracellular
 
Fig. 3.2 Schematic diagram showing the molecular organization of KCC2 
and cloning of fusion proteins. KCC2 is bound by intracellular N- and C-tails 
which span more than half of its molecular size. In between the intracellular 
domains there are 12 transmembrane domains, denoted by the 12 circled 
numbers. A relatively prominent extracellular domain is present between 
transmembrane domains 5 and 6, in which sites for N-linked glycosylation 
were found. Both intracellular N-tail (residues 1-102) and C-tail (residues 645-
1116) of KCC2 were subcloned into vectors expressing fusion proteins (His-
tag or GST-tag) in bacteria.   84
fraction (Fig. 3.3). On the other hand, GST-tagged fusion protein of N-tail of 
KCC2 (GST-N) was shown to be around 36kDa. Approximately 2mg of high 
purity of the fusion protein was obtained from 1L of bacterial culture after 
purification (Fig. 3.4). A hydrophobicity plot revealed that some regions within 
the C-tail of KCC2 are moderately hydrophobic (>1 in Kyte-Doolittle scale, 
Fig. 3.5), possibly contributing to the insolubility of this GST-tagged fusion 
protein of C-tail. To tackle this problem, the fusion proteins were purified 
under denaturing conditions; thus a His-tag fusion protein system was 
employed. The coding sequences of both N- and C-tails of KCC2 gene were 
subsequently subcloned into pTrcHis-2C (Invitrogen) to express a C-terminal 
6xHis tagged fusion protein. Under denaturing conditions using 8M urea and 
6M guanidine, His-tagged fusion proteins of N- and C-tails of KCC2 (His-N 
and His-C respectively) were purified. SDS-PAGE followed by Coomassie 
staining of the gel confirmed the expression and purity of both fusion proteins 
(Fig. 3.4). The molecular weight of His-N and His-C were found to be 13kDa 
and 47kDa respectively. Approximately 0.2mg and 0.4mg respectively of the 
fusion proteins were obtained from 100mL bacterial culture. 
 
3.2  In vitro phosphorylation of His-C by PKC 
 
To determine whether N- and C-tails of KCC2 can be phosphorylated, purified 
fusion proteins were subject to in vitro kinase assay using purified kinase and 
[γ-
32P]ATP as previously described (Moss et al., 1992). Both cAMP-dependent 
protein kinase (PKA) and Ca
2+/phospholipid-dependent protein kinase (PKC)    85
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Fig. 3.3 Expression of GST-tagged C-tail fusion protein of KCC2 in E. Coli. 
Bacteria transformed with construct expressing GST-tagged C-tail of KCC2 
were grown and fusion protein induced by 0.2mM IPTG for up to 4h. Bacterial 
lysates from 0, 2 and 4h after induction were resolved by SDS-PAGE and 
stained by Coomassie blue. Arrow indicates the expression of fusion protein at 
97kDa. Purified fraction and insoluble pellet fraction during purification were 
resolved by SDS-PAGE and stained with Coomassie blue.   86
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Fig. 3.4 Expression of GST-tag and His-tag fusion proteins of KCC2 in E. 
Coli. Purified GST-tagged N-tail (GST-N), His-tagged N-tail (His-N) and His-
tagged C-tail (His-C) of KCC2 were resolved by SDS-PAGE and stained with 
Coomassie blue. The molecular weight of the fusion proteins are 36kDa, 
13kDa and 47kDa respectively, as indicated by arrows.   87
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Fig. 3.5 Hydrophobicity plot of KCC2. The amino acid sequence of KCC2 
was analyzed using the Kyte-Doolittle scale with a window size of 20 amino 
acids. Regions with a value above 0 are hydrophobic and those below 0 are 
hydrophilic. The N-tail, transmembrane domains (TMD) and C-tail of KCC2 
are shown correspondingly as a diagram below the hydrophobicity plot. 
Putative PKC and PTK phosphorylation sites are indicated by arrows.   88
were tested. The reaction was stopped at 30min and analyzed by SDS-PAGE 
followed by autoradiography. It was found that GST-N cannot be 
phosphorylated by PKA or PKC (GST-N was minimally phosphorylated to a 
level similar to that of GST control); while the intracellular domain of R2-
subunit of GABAB receptor and β3-subunit of GABAA receptor were highly 
phosphorylated under the same condition (Fig. 3.6). However, His-C was 
found to be phosphorylated by PKC but not PKA (Fig. 3.7). To study the 
kinetics of phosphorylation of His-C by PKC, reaction products from reactions 
of different durations were subject to scintillation count of 
32P. The fraction of 
phosphorylated fusion protein was calculated using equations from section 2.24. 
It was found that phosphorylation of His-C by PKC followed in a time-
dependent manner. The reaction reached a plateau at about 30min at which 
time 0.6mole/mole of His-C was phosphorylated (Fig. 3.8). 
 
As detailed above, by comparing with the consensus PKC phosphorylation 
sequence we identified several putative phosphorylation sites on both N- and 
C-tails of KCC2 (Fig. 3.1). However, as shown in Fig. 3.6, the N-tail of KCC2 
was not phosphorylated by PKC, indicating that Thr
34 in N-tail of KCC2 is not 
a PKC phosphorylation site. Nevertheless, C-tail of KCC2 was highly 
phosphorylated by PKC (Fig. 3.7) so phosphorylation site(s) must be present in 
this region. To identify the phosphorylation site(s) within the C-tail of KCC2, 
two truncations of His-C were constructed. First, amino acids from 932 to 1043 
of C-tail of KCC2 were deleted and the result named His-C-Δ. This truncation 
contains possible phosphorylation sites of PKC: Ser
728 and Thr
787. Secondly, 
the deleted 112 amino acids in His-C-Δ (i.e. 932 to 1043) were subcloned into    89
 
 
 
 
 
45
31
GST β3G S T - N
PKA
GST β3 GST-N
PKC
CR2
45
31
kDa
Autoradiograph
Coomassie
 
Fig. 3.6 GST-N fusion protein is not phosphorylated by PKA or PKC in 
vitro. The fusion protein was tested in an in vitro kinase assay using [γ-
32P]ATP. CR2, the intracellular domain of GABAB receptor R2-subunit, and β3, 
the GABAA receptor β3-subunit, were used as positive controls for both PKA 
and PKC phosphorylation. GST, the GST tag alone, was used as negative 
control for both experiments. Upper panel: autoradiograph of the kinase assay 
showing phosphorylation of proteins. Lower panel: Coomassie blue staining of 
the same gel showing the loading of the fusion proteins.   90
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Fig. 3.7 His-C is phosphorylated by PKC but not PKA in vitro. His-N and 
His-C were tested in an in vitro kinase assay using [γ-
32P]ATP. CR2 was used 
as positive control for PKA phosphorylation. Reaction products were resolved 
by SDS-PAGE and analyzed by autoradiography showing phosphorylation of 
proteins. The gel was stained with Coomassie blue to show the presence of 
fusion proteins.   91
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Fig. 3.8 Phosphorylation kinetics of His-C by PKC. His-C was tested in an 
in vitro kinase assay using purified PKC and [γ-
32P]ATP. Phosphorylation level 
of His-C was monitored by scintillation count of 
32P in the kinase reaction for 
up to 30min. The proportion of phosphorylated protein (in terms of mole of 
phosphorylated protein per mole of protein substrate, mole/mole) was 
calculated.   92
pTrcHis2C to express His-112 fusion protein. This fusion protein harbors two 
other putative PKC phosphorylation sites: Ser
940 and Ser
1034. To determine 
whether these truncated fusion proteins can be phosphorylated by PKC, an in 
vitro kinase assay using [γ-
32P]ATP was performed. It was found that the 
phosphorylation level of His-C-Δ was not significantly lower compared to the 
highly phosphorylated His-C (Fig. 3.9), suggesting that Ser
728 and Thr
787 were 
not major PKC phosphorylation sites. On the other hand, His-112 remained 
highly phosphorylated (Fig. 3.9), indicating the presence of PKC 
phosphorylation sites in this region. To pinpoint the PKC phosphorylation sites 
in His-C, a series of serine-to-alanine mutations was constructed by site-
directed mutagenesis. These substitution mutations essentially removed the 
particular site for phosphorylation (serine) but conserved the secondary and 
tertiary structure of expressed proteins due to the structural similarity of serine 
and alanine (Moss et al., 1992). All the mutant fusion proteins were purified 
and the expressions were confirmed by SDS-PAGE followed by Coomassie 
blue staining. They were then tested by an in vitro kinase assay using [γ-
32P]ATP as detailed above. The phosphorylation levels of these mutants were 
compared to those of the wild-type (WT) His-C (Fig. 3.10). Significantly, it 
was found that single mutation of Ser
940 into alanine (S940A) reduced the level 
of phosphorylation to 32.5±2.5% of WT, while mutation of Ser
728 or Ser
1034 
into alanine residues S728A and S1034A respectively remained highly 
phosphorylated (Fig. 3.10). Notably, double mutations (S728/940A, 
S940/1034A) or a triple mutation (S728/940/1034A) showed a further 
reduction of phosphorylation level compared to that of S940A, indicating that 
other possible phosphorylation sites may play a role in KCC2 phosphorylation    93
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Fig. 3.9 Phosphorylation of truncated fusion proteins of His-C in vitro. 
Coding sequence of C-tail of KCC2 with a deletion of amino acids from 932-
1043 was subcloned into pTrcHis2C to generate His-C-Δ fusion protein. 
Similarly, coding sequence of amino acids from 932-1043 of KCC2 was 
subcloned into pTrcHis2C to generate His-112 fusion protein. Putative PKC 
phosphorylation sites on the fusion proteins were indicated as S for serine and 
T for threonine and are numbered accordingly. Both truncation fusion proteins 
were tested in an in vitro kinase assay using PKC and [γ-
32P]ATP. Reaction 
products were resolved by SDS-PAGE and analyzed by autoradiography. GST-
N was used as a negative control and β3-subunit of GABAA receptor as a 
positive control for PKC phosphorylation. Coomassie blue staining shows the 
loading of the purified fusion proteins of the same gel.   94
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Fig. 3.10 Site-directed mutagenesis of His-C and in vitro kinase assay of the 
mutant fusion proteins. Serine-to-alanine mutations of His-C were generated 
by site-directed mutagenesis. Single mutations of His-C include S728A, S940A 
and S1034A. Double mutations include S728A/S940A and S940/S1034A. 
Triple mutation S728A/940/1034A was also generated. Mutant fusion proteins 
of His-C were tested in an in vitro kinase assay using PKC and [γ-
32P]ATP. 
Upper panel: autoradiograph of reaction products after SDS-PAGE shows the 
level of phosphorylation of each fusion protein compare to that of wild-type 
(WT) of His-C. Coomassie blue staining shows the equal loading of fusion 
proteins in each comparison. Lower panel: quantification of the autoradiograph 
shown on the upper panel. [*, significantly different from WT (p < 0.01; value 
= mean±SEM, Student's t-test, n = 3)]   95
by PKC. Together, these results strongly suggested that Ser
940 residue is the 
major PKC phosphorylation site of KCC2. 
 
To investigate the charge environment and distribution of phosphorylation sites 
in His-C, a phospho-peptide map was prepared (McDonald et al., 1998). The 
32P-labeled phosphorylated His-C fusion proteins were excised from the gel 
and digested with trypsin into phospho-peptides. These tryptic phospho-
peptides were then separated by thin layer chromatography (TLC) including 
electrophoresis and chromatography in 2-dimension and visualized using a 
phospho-imager. It was found that there were two major positively charged 
phospho-peptides in WT but that one of them was removed in the S940A 
mutant (Fig. 3.11). Interestingly, a phospho-peptide map of His-C-Δ closely 
resembles that of the S940A mutant, indicating that the phospho-peptides of 
both fusion proteins are of similar identity (Fig. 3.11). In addition, the presence 
of other minor bands in the phospho-peptide maps of S940A and His-C-Δ 
indicated that these proteins were phosphorylated, possibly at other putative 
PKC phosphorylation sites. One such possible site is Ser
728 since a minor 
reduction of phosphorylation level was observed in double mutant S728/940A 
compared to that of S940A (Fig. 3.10). 
 
Besides phospho-peptide mapping, the composition of phospho-residues in 
His-C phosphorylated by PKC was investigated. The tryptic phospho-proteins 
were hydrolyzed by 6N HCl into single amino acids. The final products were 
resolved on a TLC plate using electrophoresis. Phospho-amino acids were 
separated due to their different mobility in electrophoresis and their positions    96
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Fig. 3.11 Phospho-peptide map of His-C and its mutants. 
32P-labeled His-C, 
mutant S940A and truncation His-C-Δ fusion proteins were excised from the 
gel and digested with trypsin overnight to yield phospho-peptides. The digested 
products were separated by electrophoresis followed by chromatography in two 
dimensions. Autoradiography shows the locations of phospho-peptides, which 
were indicated and numbered on each map.   97
compared with those of the standards. Autoradiography of the phospho-amino 
acids showed that His-C was entirely phosphorylated at the serine residue, an 
observation similar to mutation S940A and truncation His-C-Δ (Fig. 3.12). 
 
3.3  Expression of KCC2-FL in HEK-293 cells 
 
In the previous sections experiments were performed using purified fusion 
proteins from bacteria in an in vitro system. In order to carry out the 
investigation in a more physiologically related system, KCC2 proteins were 
expressed in HEK-293 cells. To express KCC2 molecules in mammalian cells, 
the cDNA encoding the full length of KCC2 was subcloned into a pRK5 
expression construct (Moss et al., 1991) to form KCC2-FL. The expression of 
KCC2 protein was first confirmed by western blotting using an anti-KCC2 
antibody. It was found that a major band of molecular weight of 140kDa was 
present in KCC2-FL transfected cells but not in vector transfected control (Fig. 
3.13). Furthermore, bands of molecular weight of 120kDa, 100kDa and 60kDa 
are degradation products and a band of 220kDa possibly results from 
dimerization of the KCC2 molecules (Williams et al., 1999). Interestingly, 
single mutations of S940A and Y1087F were expressed with identical 
molecular weight as WT (Fig. 3.13), suggesting that the expression of KCC2 
proteins was not affected by these mutations. Immunoprecipitation of KCC2 
from transfected cells showed that two bands were present, a pattern similar to 
that observed in transfected cells expressing KCC2 (Fig. 3.14). The appearance 
of KCC2 molecules as two distinct sizes may be due to the N-link 
glycosylation of proteins when expressed in recombinant systems as described    98
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Fig. 3.12 Phospho-amino acid analysis of His-C and its mutants. 
32P-labeled 
His-C, mutant S940A and truncation His-C-Δ fusion proteins excised from the 
gel were hydrolyzed by 6N HCl at 100ºC for 1h to become signal amino acids. 
The final products were loaded onto a TLC plate together with phospho-amino 
acid standards and resolved by electrophoresis. Locations of phospho-serine 
(PS), phospho-threonine (PT), phospho-tyrosine (PY) and the origins of 
electrophoresis are indicated by arrows. Autoradiography shows 
phosphorylation of serine, threonine or tyrosine residues for each fusion protein.   99
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Fig. 3.13 Expression of KCC2 in HEK-293 cells. The full length coding 
sequence of KCC2 was subcloned into a pRK5 vector to form KCC2-FL in 
which the expression of KCC2 was driven by a strong mammalian cytomegalo 
virus (CMV) promoter. Single mutation substitution of Ser
940 by alanine 
(S940A) and Tyr
1087 by phenylalanine (Y1087F) were made subsequently by 
site-directed mutagenesis. Purified plasmids of wild-type (WT) KCC2-FL, 
mutants and pRK5 vector were transfected into HEK-293 cells. One day after 
transfection cells were harvested and the cell lysates analyzed by SDS-PAGE 
followed by western blotting. Expression of KCC2 was detected by 
immunoblotting (IB) with anti-KCC2 antibody. An antibody against α-tubulin 
(α-Tub) was used to show equal loading of proteins in SDS-PAGE.   100
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Fig. 3.14 Immunoprecipitation of KCC2-FL from HEK-293 cells. Cells 
transfected with KCC2-FL plasmid were lyzed and KCC2 immunoprecipitated 
(IP) by polyclonal rabbit anti-KCC2 antibody coupled to protein A-sepharose. 
The product was resolved by SDS-PAGE followed by immunoblotting (IB) 
using monoclonal mouse anti-KCC2 antibody. Non-specific rabbit IgG was 
used as control in immunoprecipitation. Transfected cell lysate before 
immunoprecipitation was also analyzed by western blotting.   101
previously (Williams et al., 1999). It was shown that treatment of N-
glycosidase of cell lysate expressing KCC2 before SDS-PAGE and western 
blotting significantly reduced the molecular weight of KCC2 to around 120kDa, 
the size predicted from its cDNA (Williams et al., 1999). 
 
To analyze KCC2 in transfected cells, a metabolic whole-cell labeling 
experiment using 
35S-methionine was also performed. Cells were incubated 
with 
35S-methionine for 4h before immunoprecipitation of KCC2. Two bands 
of approximately 120kDa and 140kDa were observed in cells transfected with 
KCC2-FL but not in control vector (Fig. 3.15). Importantly, expression levels 
of mutant S728A and S940A were similar to that of WT, indicating that 
expression and degradation of KCC2 proteins were not affected by these 
mutations. 
 
3.4  Phosphorylation of KCC2-FL in HEK-293 cells 
 
From the previous in vitro kinase assay, it has been shown that Ser
940 is the 
major PKC phosphorylation site on KCC2. To confirm that this residue is 
phosphorylated by PKC in cells, a metabolic whole-cell labeling method using 
[
32P]orthophosphoric acid was employed. Cells transfected with KCC2-FL 
expression constructs were incubated with [
32P]orthophosphoric acid to allow 
incorporation of 
32P into the proteins. KCC2 molecules were then 
immunoprecipitated as described previously (Fig. 3.14) and resolved by SDS-
PAGE. Phosphorylation level of KCC2 was then monitored by 
autoradiography. It was found that WT KCC2 was basally phosphorylated and    102
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Fig. 3.15 Metabolic 
35S-methionine labeling of KCC2-FL in HEK-293 cells. 
Cells transfected with KCC2-FL WT, mutants (S728A and S940A) and pRK5 
vector alone were labeled with 
35S-methionine for 4h before 
immunoprecipitation using polyclonal rabbit anti-KCC2 antibody. The 
products were resolved by SDS-PAGE and the incorporation of radioisotope 
35S monitored by phospho-imager.    103
that the phosphorylation level was significantly increased (p<0.01) by the 
15min treatment of 100nM PDBu, a specific PKC activator, to 195.7±5.6% of 
basal condition (Fig. 3.16). Interestingly, mutant S940A was also basally 
phosphorylated; however the effect seen in WT by PDBu was totally blocked 
by this mutation (Fig. 3.16). These results strongly suggested that Ser
940 is the 
major site of PKC phosphorylation in KCC2. 
 
3.5  Expression of endogenous KCC2 in cultured hippocampal neurons 
 
As detailed above phosphorylation of the intracellular domains of KCC2 
expressed in HEK-293 cells has been examined. The advantages of using such 
recombinant systems to investigate phosphorylation are that the protein in 
question (i.e. KCC2) is expressed in high abundance and mutations can be 
introduced to pinpoint the site(s) of phosphorylation. However, these 
experiments serve only as a guide to possible events in neurons. The 
availability of kinase(s) to KCC2 in neurons may be different from that in 
recombinant systems. Therefore it is crucial to analyze the phosphorylation of 
KCC2 in neurons. Studies have revealed that expression of KCC2 is high in 
cortex and hippocampus (Woo et al., 2002; Bayatti et al., 2007; Molinaro et al., 
2007; Pathak et al., 2007). Since hippocampus is the primary region for 
learning and memory and has been investigated extensively in GABAergic 
function (Cooper et al., 1999; Brunig et al., 2001; Coulter and Carlson, 2007), 
cultured hippocampal neurons were used in the following studies. 
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Fig. 3.16 Metabolic 
32P labeling of KCC2-FL in HEK-293 cells. Cells were 
transfected with WT KCC2-FL and its mutant S940A. One day after 
transfection cells were labeled with [
32P]orthophosphoric acid for 4h. KCC2 
proteins from cells under basal condition or those treated with 500nM PDBu 
for 15min were immunoprecipitated and resolved by SDS-PAGE. 
Phosphorylation of KCC2 was monitored by phospho-imager. Upper panel: 
autoradiograph showing phosphorylation of immunoprecipitated KCC2. Lower 
panel: quantification of autoradiograph. [*, significantly different from basal 
condition (p < 0.01; value = mean±SEM, Student's t-test, n = 3)]   105
Hippocampal neurons from E18 pups of rat were dissected and plated on 
culture dishes. The cell lysates of different age (weeks) of culture were 
analyzed by SDS-PAGE and the amount of KCC2 expression visualized by 
western blotting. It was found that endogenous KCC2 proteins have a 
molecular weight of 120kDa as predicted from its coding sequence, and that its 
expression level increased from week 2 to week 5 (Fig. 3.17), which 
approximates with the results of other studies (Ludwig et al., 2003). Therefore 
cultures of 4 to 5 weeks were used in further studies. First we examined if 
KCC2 could be immunoprecipitated from these cells. To do so cultures were 
lyzed and detergent soluble fractions were immunoprecipitated with non-
specific rabbit IgG and anti-KCC2 antibody. It was found that a band at around 
120kDa was observed when using anti-KCC2 antibody but not in non-specific 
rabbit IgG control (Fig. 3.18).  
 
3.6  Phosphorylation of endogenous KCC2 in cultured hippocampal 
neurons 
 
To investigate phosphorylation of endogenous KCC2, whole-cell labeling 
experiments using [
32P]orthophosphoric acid were performed. 4h after 
32P 
incubation, neurons were lyzed and endogenous KCC2 proteins were 
immunoprecipitated. The proteins were resolved by SDS-PAGE and monitored 
by phospho-imager. It was found that KCC2 was basally phosphorylated (Fig. 
3.19). Treatment with 500nM PDBu for 15min before cell lysis significantly 
increased (p<0.01) the phosphorylation level of KCC2 to 395.5±22.3% of basal 
condition (Fig. 3.19). Interestingly, treatment with 10μM GF109203X, a     106
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Fig. 3.17 Expression of KCC2 in cultured hippocampal neurons from 0 to 
8 weeks. Hippocampal neurons from rat E18 pups were maintained in culture 
medium for up to 8 weeks. Cell lysates of different age (weeks) neurons were 
collected and resolved by SDS-PAGE followed by western blotting using anti-
KCC2 antibody. The lower panel shows the quantification of KCC2 expression 
in 8 weeks of cultures.   107
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Fig. 3.18 Immunoprecipitation of endogenous KCC2 from cultured 
hippocampal neurons. Endogenous KCC2 proteins from cultured 
hippocampal neurons were immunoprecipitated using polyclonal rabbit anti-
KCC2 antibody and resolved by SDS-PAGE followed by western blotting. 
Non-specific rabbit IgG was used as control in immunoprecipitation.   108
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Fig. 3.19 Metabolic 
32P labeling of KCC2 in cultured hippocampal neurons. 
Four-week-old cultured hippocampal neurons were labeled with 
[
32P]orthophosphoric acid for 4h and endogenous KCC2 immunoprecipitated 
and resolved by SDS-PAGE. Phosphorylation of KCC2 was monitored using a 
phospho-imager. Upper panel: autoradiograph of immunoprecipitated KCC2 
from neurons. Non-specific rabbit IgG was used as control for 
immunoprecipitation. 500nM PDBu was used for PKC activation and 10μM 
GF109203X (GFX) was used as a specific PKC inhibitor. Lower panel: 
quantification of the phospho-imager results. [*, significantly different from 
basal condition (p < 0.01; value = mean±SEM, Student's t-test, n = 3)]   109
specific PKC inhibitor, significantly reduced (p<0.01) basal phosphorylation of 
KCC2 to 15.5±3.5% of basal and blocked the effect of PDBu treatment. Thus 
endogenous KCC2 in hippocampal neurons is phosphorylated by PKC 
activation. 
 
To further study phosphorylation of endogenous KCC2 in neurons, phospho-
peptide map and phospho-amino acid analysis were performed. Phospho-
peptide mapping of endogenous KCC2 revealed that there were two major 
phospho-peptides after PDBu treatment (Fig. 3.20), a pattern resembling that of 
His-C (Fig. 3.11). Intriguingly, phospho-amino acid analysis showed that 
endogenous KCC2 is phosphorylated on serine residues under basal conditions 
(Fig. 3.21), which is similar to that of His-C (Fig. 3.12). Furthermore, PDBu 
treatment stimulated phosphorylation on tyrosine residues, an effect blocked by 
100nM calphostin C (CalC), a specific PKC inhibitor (Fig. 3.21). 
 
3.7  Phosphorylation of KCC2-FL at tyrosine residue in HEK-293 cells 
 
In addition to serine/threonine protein kinase PKC, phosphorylation of KCC2 
by tyrosine kinase was also studied. In particular Tyr
1087 has been shown to 
modulate KCC2 expression but whether this residue is actually phosphorylated 
remain to be addressed (Wake et al., 2007). Immunoprecipitation of KCC2 
proteins from HEK-293 cells transfected with KCC2-FL constructs (WT and 
Y1087F) followed by immunoblotting using phospho-tyrosine antibody 
showed that KCC2 was not phosphorylated at tyrosine residue but only if 
100μM of sodium pervanadate (Na3VO4) was added to the culture 1h before    110
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Fig. 3.20 Phospho-peptide map of KCC2 in cultured hippocampal neurons. 
32P-labeled endogenous KCC2 proteins before (basal) and after PDBu 
treatment (PDBu) were immunoprecipitated and resolved by SDS-PAGE. The 
phosphorylated protein was excised from the gel and digested overnight by 
trypsin to yield phospho-peptides. The product was then loaded onto a TLC 
plate and subject to electrophoresis and chromatography in 2 dimensions. The 
phospho-peptides are indicated by arrows.   111
 
 
 
 
 
 
PS
PT
PY
Basal PDBu Calphostin C
 
Fig. 3.21 Phospho-amino acid analysis of endogenous KCC2 in cultured 
hippocampal neurons. 
32P-labeled endogenous KCC2 proteins were 
hydrolyzed by 6N HCl to become single amino acids. The final products were 
loaded onto a TLC plate with phospho-amino acid standards and separated by 
electrophoresis. KCC2 proteins from neurons at basal condition, 500nM PDBu 
treated neurons and 100nM calphostin C treated neurons were tested. Location 
of phospho-serine (PS), phospho-threonine (PT) and phospho-tyrosine (PY) are 
indicated by arrows.   112
cell lysis (542±19% of control, Fig. 3.22). This indicated that endogenous 
phosphatase activity in cultured cells is high. Interestingly, mutation at Tyr
1087, 
the putative tyrosine phosphorylation site of KCC2, did not significantly reduce 
tyrosine phosphorylation of KCC2 under Na3VO4 treatment (Fig. 3.22), 
suggesting the presence of other tyrosine phosphorylation site(s) in the 
sequence of KCC2. 
 
To investigate whether KCC2 expressed in cells can be phosphorylated by Src 
tyrosine kinase, v-Src, the constitutively active form of Src, was co-expressed 
with KCC2-FL in HEK-293 cells. V-Src is closely related to proto-oncogene c-
Src but its inhibitory phosphorylation site was removed so v-Src becomes 
constitutively active (Roskoski, 2004). V-Src has also been shown to 
phosphorylate GABAA receptor at tyrosine residue (Moss et al., 1993); thus it 
is a good candidate to study tyrosine phosphorylation of KCC2. Since it has 
been shown that endogenous tyrosine phosphatase activity in cultured neurons 
is high (Fig.3.22), cells were treated with Na3VO4 for 1h before lysis and 
KCC2 proteins were immunoprecipitated followed by immunoblotting using 
phospho-tyrosine antibody. It was found that co-expression of v-Src 
significantly increased (p<0.01) the phospho-tyrosine level of KCC2 to 
385.5±22.2% of control (Fig. 3.23). Intriguingly, mutant Y1087F did not 
reduce tyrosine phosphorylation level of KCC2 when v-Src was co-expressed 
(Fig. 3.23), suggesting that v-Src kinase phosphorylated other site(s) on KCC2 
but not Tyr
1087. 
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Fig. 3.22 KCC2-FL was phosphorylated at tyrosine residue in HEK-293 
cells. HEK-293 cells were transfected with KCC2-FL (WT and Y1087F) and 
treated with (+) or without (-) 100μM Na3VO4 for 1h. KCC2 was 
immunoprecipitated and the proteins resolved by SDS-PAGE followed by 
western blotting using anti-phospho-tyrosine antibody (P-Y). Cell lysates 
before immunoprecipitation were also analyzed by western blotting using anti-
KCC2 antibody. The phosphorylation level of KCC2 was normalized with the 
total amount of KCC2 expression. [*, significantly different from control (p < 
0.01; value = mean±SEM, Student's t test, n = 4)]   114
 
 
 
WT Y1087F
v-Src -+ -+
P-Y
KCC2
N
o
r
m
a
l
i
z
e
d
 
p
h
o
s
p
h
o
r
y
l
a
t
i
o
n
l
e
v
e
l
,
 
P
-
Y
/
K
C
C
2
(
%
 
c
o
n
t
r
o
l
) *
-+ -+
*
WT Y1087F
0
100
200
300
400
500
*p<0.01
v-Src
 
Fig. 3.23 KCC2-FL was phosphorylated by v-Src, a constitutively active 
form of Src tyrosine kinase, in HEK-293 cells. HEK-293 cells were 
transfected with KCC2-FL (WT or Y1087F) and v-Src (+) or empty vector (-). 
One day after transfection cells were treated with 100μM Na3VO4 for 1h. 
KCC2 proteins were then immunoprecipitated, resolved by SDS-PAGE and 
analyzed by western blot using anti-phospho-tyrosine antibody (P-Y). Cell 
lysates before immunoprecipitation were also analyzed by western blotting 
using anti-KCC2 antibody. The phosphorylation level of KCC2 was 
normalized with the total amount of KCC2 expression. [*, significantly 
different from vector control (p < 0.01; value = mean±SEM, Student's t-test, n 
= 3)]   115
3.8  Phosphorylation of endogenous KCC2 at tyrosine residue in 
cultured hippocampal neurons 
 
In the previous section it was shown that KCC2 proteins expressed in HEK-
293 cells were phosphorylated at tyrosine residue. To investigate whether 
endogenous KCC2 was also phosphorylated on tyrosine residues, similar 
experiments were performed on cultured hippocampal neurons. It was found 
that endogenous KCC2 was phosphorylated at tyrosine residue when Na3VO4 
was added to the culture (811±18.4% of control, Fig. 3.24), indicating that 
endogenous tyrosine phosphatase activity in cultured neurons was also high. To 
show that tyrosine phosphorylation of KCC2 proteins in neurons is mediated 
by Src family kinase, PP2, a selective inhibitor of Src family protein tyrosine 
kinase, was treated with Na3VO4 on cultured hippocampal neurons for 30min 
before cell lysis. Results showed that PP2 significantly reduced (p<0.01) the 
phospho-tyrosine level of KCC2 to 22.5±7.1% of control condition but that 
PP3, a negative control compound for PP2, which inhibits the activity of 
epidermal growth factor receptor (EGFR) kinase, did not significantly reduce 
tyrosine phosphorylation of KCC2 (Fig. 3.25). These results indicated that 
KCC2 proteins in neurons were phosphorylated by Src family kinase. 
 
Discussion 
 
In this chapter the phosphorylation of KCC2 was investigated using a range of 
different approaches.   116
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Fig. 3.24 Endogenous KCC2 in cultured hippocampal neurons was 
phosphorylated at tyrosine residue. Cultured hippocampal neurons were 
treated with (+) or without (-) 100μM Na3VO4 for 1h and endogenous KCC2 
proteins immunoprecipitated. Phosphorylation of tyrosine residue was 
monitored by western blotting using anti-phospho-tyrosine antibody (P-Y). 
Cell lysates before immunoprecipitation were also analyzed by western blotting 
using anti-KCC2 antibody. The phosphorylation level of KCC2 was 
normalized with the total amount of KCC2 expression. [*, significantly 
different from control (p < 0.01; value = mean±SEM, Student's t-test, n = 3)]   117
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Fig. 3.25 Phosphorylation of endogenous KCC2 in cultured hippocampal 
neurons was inhibited by PP2, a Src family kinase inhibitor. Na3VO4 was 
added to the neurons 1h before lysis to block endogenous tyrosine phosphatase 
activity. 10μM PP2, Src family kinase inhibitor, and 10μM PP3, a control 
compound for PP2, were added 30min before lysis. KCC2 proteins were 
immunoprecipitated from cell lysates and resolved by SDS-PAGE followed by 
western blotting using anti-phospho-tyrosine antibody (P-Y). [*, significantly 
different from control (p < 0.01; value = mean±SEM, Student's t-test, n = 3)]   118
The investigation of phosphorylation of KCC2 was initiated by in vitro studies 
using fusion proteins of N-tail (residues 1-102) and C-tail (residues 645-1116) 
intracellular domains of KCC2 expressed and purified from E. coli. It was 
found that C-tail but not N-tail of KCC2 can be phosphorylated by PKC to high 
stoichiometry. This indicated that the putative phosphorylation site on N-tail of 
KCC2 (Payne et al., 1996) was not a phosphorylation site for PKC. This can be 
explained by the fact that protein folding around the putative site makes it 
inaccessible by PKC. Indeed, putative phosphorylation sites are deduced from 
consensus sequence; thus biochemical analyses are needed to prove their true 
identities. Peptide mapping and phospho-amino acid analysis revealed that the 
C-tail fusion protein was phosphorylated at serine residue within two major 
phospho-peptides. Interestingly, mutation of Ser
940 into alanine significantly 
reduced phosphorylation of this fusion protein to around 25% of control and 
ablated one of the major phospho-peptides seen on phosphorylation of WT 
protein. However, the further reduction of phosphorylation in double or triple 
mutants of His-C indicates that Ser
728 or Ser
1034 may play a less significant role 
in phosphorylation of KCC2 that that of Ser
940. This notion is further supported 
by the phospho-peptide map of S940A mutant in which one of the peptides 
observed in His-C was not ablated (Fig. 3.11). To support the in vitro study, 
full-length KCC2 was expressed in HEK-293 cells and its phosphorylation was 
measured by immunoprecipitation after metabolic labeling with 
[
32P]orthophosphoric acid. This method allows the analysis of the overall 
change in phosphorylation of a protein in cultured cells (Moss et al., 1992). In 
conjunction with phospho-peptide mapping and phospho-amino acid analysis, 
the number of phosphorylation sites and the residues on which phosphorylation   119
occurs (i.e. serine, threonine or tyrosine) can be investigated (Moss et al., 1992). 
It was found that expressed KCC2 was basally phosphorylated and 
phosphorylation was increased robustly by activation of PKC, an effect that 
was blocked by mutation of Ser
940. Together, it was concluded that KCC2 is a 
substrate of PKC and that the major phosphorylation site within the major 
intracellular domain of KCC2 is Ser
940. 
 
In addition to recombinant systems, phosphorylation of KCC2 in neurons was 
investigated using immunoprecipitation after metabolic labeling with 
[
32P]orthophosphoric acid. Hippocampal neurons grown in culture for four 
weeks were chosen for the study due to their high expression of KCC2. It was 
found that neuronal KCC2 was basally phosphorylated and that activation of 
PKC significantly increased phosphorylation of KCC2 at serine, threonine and 
tyrosine residues. Interestingly, this observation is different from that in 
recombinant KCC2-expressed HEK-293 cells in which only serine residue was 
phosphorylated. This can be explained by the fact that the availability of 
kinases in HEK-293 cells and hippocampal neurons are different. At the same 
time, this finding strongly suggested that a signaling pathway involving 
tyrosine kinase was co-activated in regulating KCC2 when PKC was activated. 
This potentially involves a cross-talk between PTK and PKC signaling in 
cultured neurons (Fig. 3.26) (See also section 6.1). To compare 
phosphorylation of recombinant and neuronal KCC2, phospho-peptide 
mapping was used. Interestingly, neuronal KCC2 was phosphorylated at three 
distinct phospho-peptides after PKC activation, two of them highly resembling 
those observed in recombinant KCC2. Combining results from recombinant    120
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Fig. 3.26 Putative cross-talk between PKC and PTK. Schematic diagram 
showing the activation of Src (a member of PTK) followed by activation of 
PKC. PKC is capable of phosphorylation of Ser
940 (S) in KCC2 on activation 
(physiological activation mechanism unknown). Pyk2, a member of the focal 
adhesion kinase family, is in turn activated by PKC, producing a Src homology 
2 (SH2) binding domain to activate Src kinase. Activated Src kinase then 
phosphorylates tyrosine residue(s) (Y) of KCC2.   121
system and cultured neurons, it was concluded that neuronal KCC2 is a 
substrate of PKC and that its phosphorylation was increased upon PKC 
activation. 
 
A recent report has also shown that KCC2 is phosphorylated on tyrosine 
residues upon oxidative stress and/or high metabolic activity (Wake et al., 
2007). Consensus sequence analysis also showed that there is a putative 
tyrosine kinase phosphorylation site Tyr
1087 on KCC2 (Payne et al., 1996). To 
investigate if this residue is phosphorylated, immunoprecipitation of KCC2 
expressed in HEK-293 cells followed by immunoblotting using a phospho-
tyrosine antibody was employed. Intriguingly, phosphorylation of KCC2 at 
tyrosine residues was robust upon blocking of tyrosine phosphatase, consistent 
with the previous study (Wake et al., 2007). However, mutation of Tyr
1087 did 
not significantly reduce tyrosine phosphorylation, suggesting that other 
tyrosine residues are involved in this phosphorylation. In fact, a study has 
suggested that Tyr
1087 is involved in regulation of KCC2 function, possibly 
through protein-protein interaction, but it lacks evidence that Tyr
1087 itself is 
phosphorylated (Strange et al., 2000). The result presented here is thus the first 
confirmation that Tyr
1087 is not a tyrosine kinase substrate in KCC2. 
Furthermore, the involvement of v-Src in phosphorylation of KCC2 was 
demonstrated by co-expression of this tyrosine kinase with KCC2 in HEK-293 
cells. To compare with recombinant results, neuronal KCC2 was analyzed 
similarly. It was found that neuronal KCC2 was also phosphorylated at tyrosine 
residues upon inhibition of tyrosine phosphatase, an effect reversed by 
inhibiting Src family kinase but not receptor tyrosine kinase EGFR. Together,   122
it was demonstrated that tyrosine phosphorylation of KCC2 is mediated by Src 
family kinase, and that dephosphorylation of tyrosine residues in KCC2 in 
cultured cells is carried out by the high activity of tyrosine phosphatase.   123
Chapter 4  Development of a phospho-specific antibody against Ser
940 of 
KCC2 and its use to analyze KCC2 dephosphorylation 
 
Introduction 
 
In the last chapter data were presented to show that KCC2 is phosphorylated by 
PKC on Ser
940 within its major intracellular C-terminal domain using metabolic 
labeling with [
32P]orthophosphoric acid coupled with immunoprecipitation. 
However, the use of radioisotopes in studying protein phosphorylation serves 
to measure only the overall phosphorylation level of a protein, not the 
phosphorylation state of a particular site (Moss et al., 1992). For example, it 
was demonstrated that both serine and tyrosine residues were phosphorylated 
in KCC2 upon PKC activation in neurons (Fig. 3.21) although Ser
940 was the 
major PKC phosphorylation site in KCC2. Therefore, to study phosphorylation 
at Ser
940 specifically, an antibody against the phosphorylation state of Ser
940, 
namely p-S940, was developed using a previously described technique 
(Czernik et al., 1991; Jovanovic et al., 1996). The advantage of using p-S940 
over a commercially available phospho-serine antibody is that it is specific to 
Ser
940 of KCC2, enabling phosphorylation of Ser
940 to be studied individually. 
Furthermore, it is possible to carry out immunofluorescence staining of KCC2 
molecules phosphorylated at Ser
940 in mounted cells with this phospho-specific 
antibody (Xu et al., 1998). In fact, such use of a phospho-specific antibody has 
been widely used to investigate phosphorylation of other proteins including 
GABA receptors (Jovanovic et al., 2004; Kuramoto et al., 2007). 
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As p-S940 was initially developed in our laboratory it needs to be characterized 
for its specificity against the phosphorylation state of its target residue, Ser
940 
(Czernik et al., 1991; Kuramoto et al., 2007). Characterization of p-S940 was 
carried out by western blotting using His-C and cultured cells expressing 
KCC2 and its specificity against the phosphorylation state of Ser
940 confirmed 
using immunofluorescence staining. After establishing specificity of p-S940, 
this antibody was used to investigate the regulation of phosphorylation of 
Ser
940 by PKC activity. The identities of phosphatases responsible for 
dephosphorylation of this critical residue were also investigated. 
 
Regulation of phosphorylation at Ser
940 is of particular interest in the study of 
KCC2. It has been shown that Ser
940 is the major PKC phosphorylation site 
within its intracellular domain (Figs. 3.10, 3.16). In fact, phosphorylation 
events mediated through PKC play an important role in controlling K
+-Cl
- co-
transport activities in different cell types (Adragna et al., 2004; Bergeron et al., 
2006); however, a direct link between PKC phosphorylation on the KCC2 
molecule and its functional modification on co-transport activity has yet to be 
established (Strange et al., 2000). On the other hand, phosphorylation is also 
tightly regulated by phosphatases, which catalyze the removal of the phosphate 
group from a phosphorylated residue. Previous studies have indicated that 
phosphatases play regulatory roles in cation chloride co-transporters (CCC) 
(Flatman, 2002; Liedtke et al., 2005). Given the functional relevance and 
structural similarities between members of the CCC family (Gamba, 2005), 
phosphatases may be important in the regulation of phosphorylation of KCC2. 
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This chapter describes the development of a phospho-specific antibody of 
KCC2 and its application in the study of phosphorylation and 
dephosphorylation of residue Ser
940 of KCC2. Specifically the aims of this 
chapter are: 
 
1)  To show the phosphorylation-specificity of p-S940 by western blotting 
on recombinant and neuronal KCC2. 
2)  To show the phosphorylation-specificity of p-S940 by 
immunofluorescence staining. 
3)  To study regulation of phosphorylation of Ser
940 using p-S940. 
4)  To show that particular phosphatases are responsible for 
dephosphorylation of Ser
940 of KCC2. 
 
Results 
 
4.1  Production of the phospho-specific antibody of KCC2, p-S940 
 
To generate p-S940 the phospho-peptide around residue Ser
940 of KCC2 
intracellular domain (P-pep-S940) was first designed to be suitable for 
immunization. The peptide sequence for immunization is: 
    D E S R G S IRRKN 
in which the underlined S is Ser
940 that was chemically phosphorylated during 
peptide synthesis. The design of this immunizing antigen was based on several 
criteria. First, the peptide length was short at around 10 amino acids such that 
the phospho-serine residue was forced into the epitope recognized by the   126
antibody. Second, the sequence was subjected to a Blast search to reduce the 
chance of cross-reactivity with homologous protein. It is important to note that 
the region around Ser
940 is unique to KCC2 among KCC members. Finally, an 
N-terminal cysteinyl residue was added for conjugation of carrier protein and 
coupling to affinity column. After chemical synthesis of the phospho-peptide, it 
was injected into two rabbits and three subsequent boosts were administered 
within a 3-month period. The immunization schedule is listed below: 
 
Week Injection  procedure 
0  Intradermal, 0.6mg of peptides in Complete Freund’s Adjuvant 
2  Subcutaneous, 0.3mg of peptides in Incomplete Freund’s Adjuvant 
4  Subcutaneous, 0.3mg of peptides in Incomplete Freund’s Adjuvant 
5 Serum  collection 
6 Serum  collection 
7 Serum  collection 
8  Subcutaneous, 0.3mg of peptides in Incomplete Freund’s Adjuvant 
9 Serum  collection 
10 Serum  collection 
11 Serum  collection 
12  Subcutaneous, 0.3mg of peptides in Incomplete Freund’s Adjuvant 
 
Approximately 15mL serum from the animal was then collected after the first 
injection. This serum was purified with affinity column coupled with phospho-
peptides. Chemical synthesis of peptides, injection of phospho-peptides into 
rabbits and purification of antibodies were all carried out by PhosphoSolutions.   127
4.2  Phosphorylation-specificity of purified p-S940  determined by 
western blotting 
 
To characterize p-S940 His-C and its S940A mutant were subjected to an in 
vitro kinase assay by PKC in the presence or absence of ATP. The reaction 
products were resolved by SDS-PAGE and analyzed by western blotting using 
p-S940. It was found that p-S940 recognized only WT His-C in the presence of 
ATP (Fig. 4.1), consistent with results shown in Fig. 3.10 in which His-C was 
highly phosphorylated by PKC but blocked significantly by S940A mutant. 
 
To further confirm the specificity of p-S940 HEK-293 cells expressing KCC2-
FL and the S940A mutant were used as in Fig. 3.13. Prior to cell lysis, cells 
were treated with 500nM PDBu for 15min to activate PKC. The cell lysates 
were then analyzed by SDS-PAGE and western blotting. It was found that there 
was basal phosphorylation of KCC2-FL in HEK-293 cells in the absence of 
PDBu (Fig. 4.2); however, treatment with PDBu significantly (p<0.01) 
increased the signal of p-S940 in WT to 218±68% of basal condition. 
Importantly, no signal was detected in S940A mutant (Fig. 4.2), indicating that 
the antibody is specific to the phosphorylation of Ser
940 of KCC2 expressed in 
the recombinant system. 
 
To determine if p-S940 could be used to examine the phosphorylation of 
neuronal KCC2 lysates of hippocampal neurons were immunoblotted with this 
antibody. Using this approach a major band of 120kDa and some very weak  
   128
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Fig. 4.1 p-S940 is specific to the phosphorylation of His-C in vitro. His-C 
(WT and S940A) was subject to in vitro kinase assay in the presence (+) and 
absence (-) of ATP. The reaction products were then resolved by SDS-PAGE 
followed by western blotting using p-S940. The amount of His-C used in the 
reactions was determined using anti-KCC2 antibody on a separate blot with the 
same amount of proteins loaded.   129
 
 
 
 
Total KCC2
-+ -+ P D B u
WT S940A
p-S940
0
100
200
300
400
-+ -+
p
-
S
9
4
0
 
s
i
g
n
a
l
 
n
o
r
m
a
l
i
z
e
d
 
b
y
t
o
t
a
l
 
K
C
C
2
 
e
x
p
r
e
s
s
i
o
n
(
%
 
b
a
s
a
l
)
WT S940A
*
*p<0.01
 
Fig. 4.2 p-S940 is specific to the phosphorylation of KCC2 expressed in 
HEK-293 cells. Cells transfected with KCC2-FL (WT and S940A) were 
treated with (+) or without (-) 500nM PDBu for 15min before cell lysis. Cell 
lysates were analyzed by SDS-PAGE and western blotting using p-S940. Anti-
KCC2 antibody was used to detect the total amount of KCC2 on a separate blot 
to show equal loading of proteins. Quantification of p-S940 signal was 
normalized with that of total expression of KCC2. [*, significantly different 
from basal condition (p < 0.01; value = mean±SEM, Student's t-test, n = 5)]   130
bands between 150kDa and 180kDa were seen with p-S940. Detection of these 
bands was abolished with a molar excess (1mg/mL) of P-pep-S940. However, 
the signal of p-S940 was not affected by incubation of non-phospho-peptide, 
pep-S940 (Fig. 4.3). Another weak band above 200kDa was seen in different 
treatments of the blots, indicating that this is not specific to phosphorylation of 
Ser
940. Interestingly, when the blot was incubated with λ-phosphatase before 
incubation of p-S940, the phospho-specific signals were all removed (Fig. 4.4). 
λ-phosphatase is known to be a Mn
2+-dependent phosphatase that removes the 
phosphate group from serine, threonine and tyrosine residues (Cohen and 
Cohen, 1989). Therefore, the removal of p-S940 signal by λ-phosphatase 
treatment suggested that p-S940 specifically recognized the phosphate group of 
KCC2 on the blot. 
 
In addition, KCC2 proteins were immunoprecipitated by anti-KCC2 antibody 
from cultured neurons and the products immunoblotted with p-S940. Results 
showed that treatment of PDBu significantly (p<0.01) increased 
phosphorylation of KCC2 by 195.4±55% compared to basal condition (Fig. 
4.5). Interestingly, this result resembled that observed in whole-cell labeling 
experiments using [
32P]orthophosphoric acid (Fig. 3.19). Together, these 
results showed that p-S940 is specific to the phosphorylation of Ser
940 of KCC2 
by PKC in cultured hippocampal neurons. 
 
4.3  Phosphorylation-specificity of purified p-S940  as determined by 
immunofluorescence staining   131
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Fig. 4.3 Competition assay using phospho- and non-phospho-peptides of 
Ser
940 of KCC2 in western blots of neuronal lysates. Cell lysate of cultured 
hippocampal neurons was resolved by SDS-PAGE followed by 
immunoblotting. During incubation of primary antibody p-S940, non-phospho-
peptide (pep-S940) or phospho-peptide (P-pep-S940) was added in molar 
excess amount. In control experiment (con) neither of the peptides was added. 
The binding of p-S940 to the membrane was recognized by HRP-conjugated 
polyclonal anti-rabbit IgG.   132
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Fig. 4.4 The effect of λ-phosphatase treatment on western blots before p-
S940 incubation. Cell lysate from cultured hippocampal neurons was resolved 
by SDS-PAGE and proteins transferred onto nitrocellulose membrane. Blots 
were treated with (+) or without (-) λ-phosphatase (λ-PPase). The treated 
membranes were then immunoblotted with p-S940. On a separate blot, the 
expression of total KCC2 was determined by immunoblotting with anti-KCC2 
antibody.   133
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Fig. 4.5 p-S940 is specific to the phosphorylation of immunoprecipitated 
KCC2 from hippocampal neurons. Cultured hippocampal neurons were 
treated with (+) or without (-) 500nM PDBu for 15min before cell lysis and 
immunoprecipitation (IP) of KCC2. Non-specific rabbit IgG was a negative 
control for IP. Proteins after IP were resolved by SDS-PAGE followed by 
immunoblotting (IB) using p-S940. The total amount of KCC2 in each lane 
was analyzed by anti-KCC2 antibody on a separate blot. Quantification of p-
S940 signal was normalized with that of total expression of KCC2. [*, 
significantly different from basal condition (p < 0.01; value = mean±SEM, 
Student's t-test, n = 3)]   134
 
In addition to western blotting the specificity of p-S940 was tested in 
immunofluorescence staining using HEK-293 cells expressing KCC2-FL and 
the S940A mutant. After PKC activation, cells were fixed and immunostained 
with anti-KCC2 antibody and p-S940 coupled to fluorescein isothiocyanate 
(FITC)- and tetramethyl rhodamine isothiocyanate (TRITC)-conjugated 
secondary antibodies respectively. It was found that p-S940 staining co-
localized exclusively with KCC2 staining, indicating its specificity to KCC2. 
Furthermore, p-S940 can detect basal phosphorylation of WT KCC2 expressed 
in HEK-293 cells (Fig. 4.6). Significantly, the signal detected by p-S940 
appeared to be increased by exposure to PDBu (Fig. 4.6). On the other hand, 
anti-KCC2 recognized the expression of S940A mutant of KCC2 in HEK-293 
cells; however, no signal was detected by p-S940 in these cells before and after 
treatment of PDBu (Fig. 4.6), indicating the specificity of p-S940 to PKC 
phosphorylation of KCC2 in an immunostaining application. To complement 
these experiments with recombinant KCC2, cultured hippocampal neurons 
were also used for immunostaining experiments. After PKC activation 
hippocampal neurons were stained with anti-KCC2 antibody and p-S940 
coupled to FITC- and TRITC- conjugated secondary antibodies respectively. 
Twenty cells each from a PKC-activated dish and a control dish were randomly 
chosen and for each cell a stack of confocal images along the vertical axis were 
taken. Each stack of confocal images was compressed together using the 
MetaMorph program to form a 3-D reconstruction of a neuronal cell. The pixel 
intensity of KCC2 staining and p-S940 staining of the dendritic regions of each 
cell was recorded. Similar to the results in HEK-293 cells, p-S940 staining    135
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Fig. 4.6 Immunofluorescence staining showing that p-S940 is specific to 
phosphorylation of KCC2 expressed in HEK-293 cells. Cells expressing 
KCC2 (WT and S940A) were subjected to immunostaining in the presence (+) 
or absence (-) of 500nM PDBu. Anti-KCC2 antibody and p-S940 were used 
and were coupled to FITC- and TRITC-conjugated secondary antibodies 
respectively. Scale bar = 50μm.   136
overlaps exclusively with KCC2. Interestingly, endogenous KCC2 proteins 
were also shown to be basally phosphorylated (Fig. 4.7). Furthermore, 
treatment of PDBu significantly (p<0.005) increased p-S940 signal in dendrites 
to 205.6±45.5% of basal value after normalized with that of total KCC2 (Fig. 
4.7). These experiments reinforced that p-S940 is specific to phosphorylation 
of KCC2 at Ser
940 and again showed the utility of this antibody in 
immunostaining applications. 
 
4.4 Regulation  of  Ser
940 phosphorylation by PKC activity in cultured 
neurons 
 
Given the ability of p-S940 to specifically detect KCC2 phosphorylated on 
Ser
940 the role that PKC activity plays in regulating the phosphorylation of this 
individual residue was addressed. To achieve this goal 4-5 week-old cultures 
were treated with PDBu for 10, 20 and 30min before cell lysis. This experiment 
serves to determine whether phosphorylation at Ser
940 is stable upon PKC 
activation since the phosphorylation of many proteins appears to be biphasic 
(Brandon et al., 2000). It was found that phosphorylation of Ser
940 was 
increased significantly (p<0.01) to 223±5.4% of basal value in 10min (Fig. 4.8). 
Intriguingly, this increase in phosphorylation was maintained steadily 
throughout a 30-min period while total expression of KCC2 remained 
unchanged. 
 
To further examine the role of PKC in mediating phosphorylation of Ser
940 the 
effects of calphostin C (CalC), a specific PKC inhibitor on basal     137
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Fig. 4.7 Immunofluorescence staining showing that p-S940 is specific to 
phosphorylation of KCC2 in cultured hippocampal neurons. Cultured 
hippocampal neurons were subjected to immunostaining under basal conditions 
(-PDBu) or after treatment of 500nM PDBu for 15min (+PDBu). Anti-KCC2 
antibody and p-S940 were used and coupled to FITC- and TRITC-conjugated 
secondary antibodies respectively. The level of p-S940 signal was quantified 
and normalized with that of total KCC2 expression in the lower panel. Scale 
bar = 50μm. [*, significantly different from basal condition (p < 0.005; value = 
mean±SEM, Student's t-test, n = 15)]   138
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Fig. 4.8 Activation of PKC by PDBu was detected by p-S940 antibody. 
Cultured hippocampal neurons were treated with 500nM PDBu from 10min to 
30min. Cell lysates were then collected and resolved by SDS-PAGE followed 
by western blotting. Upper panel: p-S940 antibody was used in western 
blotting to detect phosphorylation of KCC2. Anti-KCC2 antibody was used on 
another blot to show equal amount of total KCC2 protein. Lower panel: the 
amount of phosphorylation of KCC2 during 30min of PDBu treatment was 
quantified. [*, significantly different from basal condition (p < 0.01; value = 
mean±SEM, Student's t-test, n = 3)]   139
phosphorylation of this residue, were analyzed. Using 100nM CalC, the 
phosphorylation level of Ser
940 was reduced significantly (p<0.01) to 
78.09±8.18% of control (Fig. 4.9). These results thus suggest that 
phosphorylation of Ser
940 is regulated by PKC activity. However, the 
incomplete blockade of basal phosphorylation by CalC suggests that 
phosphorylation of Ser
940 is likely mediated by other kinases. 
 
4.5  The dephosphorylation of Ser
940 is mediated via PP1/PP2A/PP2C 
 
The dephosphorylation of serine/threonine residues is mediated via the specific 
protein phosphatase (PP) including PP1, PP2A, PP2B and PP2C (Cohen, 1989). 
To find out which phosphatase was responsible for dephosphorylation of Ser
940, 
okadaic acid (OA) was employed. As measured using in vitro analysis OA 
inhibits PP1 with an IC50 of 20nM, PP2A with an IC50 of 0.2nM, while PP2B is 
much less sensitive to this agent (IC50 = 5μM) (Cohen, 1989). In contrast PP2C 
is not sensitive to OA. Treatment of 4-5 week-old cultured neurons with OA at 
100nM significantly increased phosphorylation of Ser
940 to 192±14.4% of 
control (Fig. 4.10). This indicated that dephosphorylation of Ser
940 was carried 
out by PP1 and PP2A. To investigate whether PP2B or calcineurin was 
involved in regulation of Ser
940 phosphorylation cyclosporin A, a specific 
inhibitor of calcineurin, was used. Interestingly, it was found that cyclosporin 
A did not significantly change the phosphorylation level of Ser
940 (Fig. 4.11), 
suggesting that calcineurin is not involved in dephosphorylation of Ser
940. 
Together these results suggest a predominant role for PP1/PP2A, but not PP2B, 
in dephosphorylation of Ser
940 in KCC2.   140
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Fig. 4.9 The effect of PKC inactivation on Ser
940 phosphorylation. Cultured 
hippocampal neurons were treated with 100nM PDBu (PDBu) or 100nM 
calphostin C (CalC) for 10min before cell lysis. Proteins were resolved by 
SDS-PAGE followed by immunoblotting using p-S940. Signals from p-S940 
between control (con), PDBu and CalC were quantified and compared. [*, 
significantly different from control condition (p < 0.01; value = mean±SEM, 
Student's t-test, n = 3)]   141
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Fig. 4.10 The effect of phosphatase inhibitor on Ser
940 phosphorylation. 
Cultured hippocampal neurons were treated with 100nM okadaic acid (OA) for 
15min before cell lysis. Cell lysates were resolved by SDS-PAGE followed by 
western blotting using p-S940 antibody. Signals from p-S940 between control 
(con) and OA were quantified and compared. [*, significantly different from 
control (p < 0.01; Student's t test, n = 3)]   142
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Fig. 4.11 The effect of calcineurin inhibitor on Ser
940 phosphorylation. 
Four-week-old cultured hippocampal neurons were treated with 20μM 
cyclosporin A (CsA), a specific calcineurin inhibitor, for 15min. Proteins 
collected after cell lysis were resolved by SDS-PAGE and analyzed by western 
blotting using p-S940. Signals from p-S940 between control (con) and CsA 
were quantified and compared.   143
Because it is difficult to control for drug penetration in these experiments the 
dephosphorylation of Ser
940 was also analyzed in vitro using purified kinase 
preparations. For these experiments His-C was first phosphorylated by purified 
PKC  in vitro in the presence of ATP for 15min. The products were then 
washed extensively with PBS to stop kinase activity. The phosphorylated 
proteins were incubated with different purified phosphatases and respective 
buffers (refer to section 2 methods) for 15min at 30ºC. For control experiment, 
proteins were incubated with buffers without phosphatase. It was found that 
PP1 and PP2A were involved in dephosphorylation of Ser
940 (Fig. 4.12). The 
phosphorylation level was reduced to 28.3±15.5% and 38±6.4% of that of 
control respectively. Importantly, PP2B did not change the level of 
phosphorylation of His-C significantly (Fig. 4.12). These results were 
consistent with the studies in neurons using OA and cyclosporin A (Figs. 4.10 
and 4.11). Moreover, it was found that PP2C was able to dephosphorylate His-
C in vitro to 42.1±9.4% of control value (Fig. 4.12). 
 
Discussion 
 
In this chapter, the development of a polyclonal antibody specific to the 
phosphorylation state of Ser
940 of KCC2, namely p-S940, was documented. 
Since this phospho-specific antibody was newly raised in our laboratory, it is 
crucial to test for its specificity using different techniques, including western 
blotting and immunocytochemistry as described previously (Jovanovic et al., 
2004; Kuramoto et al., 2007).   144
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Fig. 4.12 Dephosphorylation of His-C in vitro. Purified His-C was first 
phosphorylated in an in vitro kinase assay using ATP and purified PKC. 
Phosphorylated proteins were bound to Ni
2+ resin and washed extensively 
before incubation with phosphatases including PP1, PP2A, PP2B and PP2C for 
15min. Proteins were then washed again and resolved by SDS-PAGE. 
Phosphorylation of the proteins was monitored using p-S940 antibody. 
Phosphorylation level of His-C after dephosphorylation was compared to that 
of control (without phosphatase incubation). Antibody against KCC2 was used 
to demonstrate the presence of equal amount of His-C in each reaction. [*, 
significantly different from control (p < 0.01; Student's t test, n = 3)]   145
The antibody was first tested using fusion protein His-C, which was 
phosphorylated by PKC in vitro. It was shown that p-S940 could recognize 
His-C on western blots when phosphorylated. By contrast, non-phosphorylated 
His-C was not recognized by p-S940. 
 
In addition to studies using fusion proteins, specificity of p-S940 was 
demonstrated in cultured cells using western blotting. Here, KCC2 expressed in 
HEK-293 cells and endogenous KCC2 in cultured hippocampal neurons was 
shown to have basal phosphorylation at Ser
940. Moreover, activation of PKC 
significantly increased the signal of p-S940, while total KCC2 level was not 
affected. These results are similar to those seen in whole-cell labeling 
experiments using [
32P]orthophosphoric acid in the previous chapter. However, 
the increase in p-S940 signal upon PKC activation was less than the overall 
increase using the same treatment observed in whole-cell labeling experiments. 
This can be explained by the fact that phosphorylation sites other than Ser
940 
were phosphorylated upon PKC activation. In chapter 3 it was shown that 
Ser
728 and Ser
1034 may play roles in phosphorylation of KCC2. Tyrosine 
phosphorylation of KCC2 was also observed using tyrosine phosphatase 
inhibitor sodium pervanadate. There is a possible cross-talk between PKC and 
PTK signaling pathways (Burry, 1998; Morishita et al., 2007) (See also section 
6.1). Apart from PKC activation, specificity of p-S940 was further 
demonstrated by λ-phosphatase treatment of western blot and competition 
assay using a phospho-peptide of Ser
940. The complete removal of p-S940 
signal in those experiments strongly suggests that this antibody is specific to 
the phosphorylation state of Ser
940.   146
 
In addition to western blotting, immunocytochemistry was employed to 
demonstrate the specificity of p-S940. When KCC2 was expressed in HEK-293 
cells, p-S940 recognized phosphorylation only of WT KCC2, not S940A 
mutant. Furthermore, PKC activation increased p-S940 signal of WT KCC2, 
indicating its specificity. Similarly, immunostaining of cultured hippocampal 
neurons using p-S940 revealed that phosphorylation of KCC2 was significantly 
increased by activation of PKC, a result consistent with western blot studies. 
 
After establishing the specificity of p-S940, this antibody was employed to 
further investigate the phosphorylation of Ser
940. First, phosphorylation of 
Ser
940 was investigated in a time course of PKC activation. It was found that 
the phosphorylation of Ser
940 in mature neurons was increased during 10min of 
PKC activation and its level stayed the same for 30min, which is comparable to 
that observed in in vitro phosphorylation of His-C. Phosphorylation depends on 
an orchestrated action of kinases and phosphatases inside cells; therefore the 
identity of the phosphatase that dephosphorylates Ser
940 was also explored. 
Using selective inhibitors of phosphatases, it was shown that both PP1 and 
PP2A dephosphorylated Ser
940, while PP2B did not. To complement this study, 
an in vitro dephosphorylation assay using His-C and [γ-
32P]ATP was employed. 
In addition to PP1 and PP2A, PP2C was also found to be involved in the 
dephosphorylation of Ser
940.   147
Chapter  5  Phospho-dependent modulation of KCC2 cell surface 
expression and activity 
 
Introduction 
 
It was established in the previous chapters that KCC2 is directly 
phosphorylated by PKC and the Src family tyrosine kinase. To study how these 
phosphorylation events regulate the function of KCC2, its cell surface 
expression and co-transport activities were investigated. KCC2 carries out its 
function by co-transporting K
+ and Cl
- across the neuronal membrane; 
therefore its cell surface expression is crucial in determining its efficacy in co-
transport function. To measure the cell surface expression of KCC2, a 
biotinylation assay was employed as described previously (Fairfax et al., 2004). 
First, the amount of cell surface KCC2 under PKC activation was determined 
by immunoblotting. Using a biotinylation method, labeled proteins were 
allowed to undergo endocytosis and the rate of endocytosis of KCC2 was also 
determined. To demonstrate the essential role of Ser
940 in KCC2 cell surface 
expression and endocytosis, mutant S940A was expressed in HEK-293 cells 
and its response to PKC activation was compared to that of WT KCC2. 
Immunostaining of KCC2 was employed to confirm the results from cell 
surface biotinylation. Here, the subcellular distribution of KCC2 was recorded 
by measuring the signal intensity of a line scan across a cell expressing KCC2 
molecules. The effect of PKC activation on the distribution of KCC2 was then 
compared. 
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KCC2 co-transport activity was also directly assessed by an 
86Rb
+ influx assay 
in HEK-293 cells. Due to the similar atomic size between 
86Rb
+ and K
+, the 
former was used as a substitute for K
+ to monitor the influx rate of ions in an 
isotonic condition. The role of PKC activation on KCC2 activity was first 
demonstrated in HEK-293 cells expressing KCC2 molecules. To investigate 
the role of Ser
940 in mediating KCC2 function under PKC activation, S940A 
mutant was used and compared to WT KCC2. Overall, this chapter focuses on 
the functional consequence of phosphorylation of KCC2 molecules. 
Specifically, the aims of this chapter are: 
 
1)  To show that cell surface expression of KCC2 is modified upon 
phosphorylation by PKC. 
2)  To show that endocytosis of KCC2 is modified upon phosphorylation 
by PKC and that phosphorylation of Ser
940 is essential in this process. 
3)  To show that subcellular distribution of KCC2 is modified upon 
phosphorylation by PKC. 
4)  To show that KCC2 co-transport activity is altered by phosphorylation 
mediated by PKC. 
 
Results 
 
5.1  Investigation of cell surface expression of KCC2 using biotinylation 
 
The biotinylation labeling method was used to quantify the amount of KCC2 
expressed on the cell surface of HEK-293 cells. Cell surface proteins were   149
labeled with Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific, Inc.), which 
binds covalently to any available primary amines. After extensive washing, 
HEK-293 cells expressing KCC2 were lysed and proteins labeled with Sulfo-
NHS-SS-Biotin were captured by NeutrAvidin resin. Labeled proteins were 
eluted by reducing reaction using 0.2M β-mercaptoethanol and resolved by 
SDS-PAGE. The amount of cell surface KCC2 was then quantified by 
immunoblotting with anti-KCC2 antibody and expressed as a percentage of the 
total fraction of the cell. It was found that 22.9±4.5% of WT KCC2 was present 
on the cell surface at steady state, and this could be increased significantly 
(p<0.01) to 40.6±5.4% in 15min upon activation of PKC (Fig. 5.1). 
Interestingly, 38.7±4.6% of S940A mutant of KCC2 was found in biotin-
labeled fraction at steady state, a level significantly higher than that of WT. 
However, PDBu treatment did not significantly increase the cell surface 
expression of this mutant (Fig. 5.1), suggesting that phosphorylation of Ser
940 
is essential to the change of KCC2 cell surface level upon PKC activation. To 
confirm this result, a biotinylation assay was performed on cultured 
hippocampal neurons. It was found that activation of PKC with PDBu 
produced a significant increase (p<0.001) in neuronal cell surface KCC2 to 
395.6±9.9% of control, an effect that was blocked by a specific PKC inhibitor, 
calphostin C (Fig.5.2). 
 
5.2  Endocytosis of KCC2 in HEK-293 cells is modified by PKC 
activation 
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Fig. 5.1 Biotinylation assay of KCC2 expressed in HEK-293 cells. Cells 
transfected with KCC2-FL (WT and S940A mutant) were treated with (+) or 
without (-) 500nM PDBu for 15min. Cell surface proteins labeled by Sulfo-
NHS-SS-Biotin were pulled down by NeutrAvidin resin. Proteins were then 
resolved by SDS-PAGE followed by western blot. On a separate blot, 1% of 
total lysate was loaded and the amount of KCC2 was determined by anti-KCC2 
antibody. [*, significantly different from basal condition (p < 0.01; value = 
mean±SEM, Student's t-test, n = 4)]   151
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Fig. 5.2 The effect of PKC activation on cell surface KCC2 in cultured 
hippocampal neurons. Cultured hippocampal neurons were treated with 
500nM PDBu for 15min or co-treated with 100nM Calphostin C (CalC) before 
cell surface proteins were labeled with Sulfo-NHS-SS-Biotin. Biotin-labeled 
cell surface proteins were purified on NeutrAvidin resin and resolved by SDS-
PAGE. Western blotting using anti-KCC2 antibody was used to quantify the 
amount of KCC2 in cell surface fraction and in total lysate. [*, significantly 
different from basal condition (p < 0.001; value = mean±SEM, Student's t-test, 
n = 5)]   152
The cell surface stability of a protein is affected by several factors, including 
the rate of endocytosis, the rate of surface insertion, and the rate of protein 
recycling (Fig. 5.3). To examine if PKC modulates KCC2 endocytosis, HEK-
293 cells transfected with KCC2-FL WT and S940A mutant were labeled with 
Sulfo-NHS-SS-Biotin and endocytosis was allowed to proceed at 37ºC for up 
to 20min. To prevent lysozomal degradation of any internalized proteins, 1μM 
leupeptin was added. After endocytosis and cleavage of remaining cell surface 
biotin with reduced glutathione, cells were lyzed and internalized biotinylated 
proteins captured by NeutrAvidin resin. The isolated proteins were then 
resolved by SDS-PAGE and analyzed by western blotting using KCC2 
antibody. 
 
It was found that the entire cell surface population of KCC2 was endocytosed 
within 10min under basal condition (Fig. 5.4). The process was linear over the 
initial 5min period of the assay (Fig. 5.4). Under control conditions 80.7±8.2% 
of the total cell surface population of KCC2 was internalized within 5min, 
whereas in the presence of PDBu internalization was reduced significantly 
(p<0.001) to 30.5±4.5% (Fig. 5.5). Interestingly, the endocytosis of the S940A 
mutant of KCC2 appeared to be significantly slower than that of WT over a 
time course of 20min in the presence or absence of PKC activation (Fig. 5.4). 
At 5min under control conditions, the amount of endocytosed KCC2 S940A 
was 15.6±3.2% of total cell surface population, a level significantly lower than 
that of WT (Fig. 5.5). However, in contrast to WT, PDBu treatment did not 
significantly alter the endocytosis of S940A mutant (Fig. 5.5). 
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Fig. 5.3 Factors contributing to cell surface stability of KCC2. Cell surface 
protein expression is a summation of endocytosis, re-insertion, and degradation. 
The expression of KCC2 on neuronal membrane is used as a model in this 
diagram.   154
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Fig. 5.4 Endocytosis of KCC2 in HEK-293 cells. Cells transfected with WT 
or S940A mutant of KCC2-FL were labeled with Sulfo-NHS-SS-Biotin and 
then incubated for varying time periods in the absence (-) or presence (+) of 
500nM PDBu at 37
oC to allow endocytosis. After cleavage by reduced 
glutathione the remaining biotinylated proteins were pulled down by 
NeutrAvidin resin and immunoblotted with KCC2 antibody. The percentage of 
endocytosed proteins was determined compared to total cell surface fraction 
(without cleavage).   155
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Fig. 5.5 Endocytosis of KCC2 in HEK-293 cells at 5min. The amount of cell 
surface KCC2 (WT and S940A) before endocytosis (total) and after 5min of 
endocytosis (endo) was compared. In addition, the effect of 500nM PDBu 
treatment on KCC2 endocytosis was shown. [*, significantly different from 
basal condition (p < 0.001; value = mean±SEM, Student's t-test, n = 3)]   156
5.3  Subcellular distribution of KCC2 shown by immunocytochemistry 
coupled to confocal imaging 
 
To confirm the results using biotinylation, immunocytochemistry was used to 
measure the subcellular distribution of KCC2. HEK-293 cells transfected with 
KCC2-FL WT or S940A were fixed, permeabilized and stained with KCC2 
antibody. Confocal images were taken from individual cells and the pixel 
intensity along a line scan of the mid-plane of each cell was recorded. In this 
way, the ratio of protein at cell periphery region to cytosol fraction can be 
calculated and this ratio can be an estimation of the distribution of a protein 
(KCC2 molecules) at a subcellular level. The effect of PKC activation on the 
subcellular distribution of KCC2 was also determined. It was found that PDBu 
significantly increased (p<0.01) the ratio of WT KCC2 molecules associated 
with the cell periphery by 182±7.2% of control (Fig. 5.6). However, in cells 
expressing S940A mutant, PDBu did not significantly change the subcellular 
distribution of KCC2 molecules (Fig. 5.6), results are consistent with those 
observed using a biotinylation method as outlined in section 5.1. 
 
This immunocytochemistry experiment was repeated in cultured hippocampal 
neurons. Here, the level of KCC2 membrane expression was measured by the 
ratio of fluorescence signals associated with the cell surface and the cytoplasm 
of individual proximal dendrites along a line scan of a mid-plane as shown (Fig. 
5.7). It was revealed that treatment of neurons with PDBu significantly 
increased (p<0.01) the level of KCC2 immunoreactivity at the periphery of 
dendrites to 175.5±19% of that of control neurons, but this effect was reduced    157
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Fig. 5.6 Subcellular distribution of KCC2 in HEK-293 cells. HEK-293 cells 
transfected with KCC2-FL was fixed, permeabilized and immunostained with 
anti-KCC2. Confocal images of the cells were acquired and a line scan was 
performed along the mid-plane of the cells. The pixel summation of the line 
was quantified and the profile of cells under control conditions and treated with 
500nM PDBu before fixation was compared. The ratio of signal intensity 
between membrane (position a) and cytoplasm (position b) of individual cells 
was also calculated and compared. Scale bar = 50μm. [*, significantly different 
from control condition (p < 0.01; value = mean±SEM, Student's t-test, n = 15)]   158
 
 
 
Control PDBu PDBu+CalC
Position
a
50
100
150
200
250
300
P
i
x
e
l
 
s
u
m
m
a
t
i
o
n
Control
PDBu
PDBu+CalC
0
50
100
150
200
Control
PDBu
PDBu+CalC
R
a
t
i
o
 
a
:
b
(
%
 
c
o
n
t
r
o
l
) *
*p<0.01
b
 
Fig. 5.7 Subcellular distribution of endogenous KCC2 in hippocampal 
neurons. Four-week-old hippocampal neurons were treated with 500nM PDBu 
and/or 100nM CalC for 10min. Neurons were fixed, permeabilized and stained 
with KCC2 antibody coupled to a TRITC-conjugated secondary antibody. 
Confocal images were then taken from the bottom to top of proximal dendrites 
and line scans across the dendrites performed on the mid-plane of the images as 
shown in insets. The summation of pixel intensity was calculated for cells with 
different drug treatments. The ratio of signal intensity between plasma 
membrane (position a) to cytosol (position b) was also calculated. Scale bar = 
25μm. [*, significantly different from control (p < 0.01; value = mean±SEM, 
Student's t-test, n = 20)]   159
by inhibition of PKC (Fig. 5.7). In accordance with the biotinylation results, it 
appeared that PKC activation increased expression of KCC2 on neuronal cell 
surface. 
 
5.4 K
+-Cl
- cotransport activity in HEK-293 cells 
 
Using biochemistry and immunofluorescence it was shown in the previous 
sections that activation of PKC increased cell surface expression of KCC2 in 
HEK-293 cells and cultured hippocampal neurons. To directly investigate the 
functional activity of KCC2 upon PKC activation, a furosemide-sensitive 
86Rb
+ 
influx assay was employed. This experiment was conducted by Jeff Williams 
in collaboration with the laboratory of Dr. John Payne at UC Davis. HEK-293 
cells were initially transfected with KCC2-FL WT or a series of mutants 
including S728A, T787A, S940A, S1034A and double mutants S940/1034A 
and S728/940A. On the day of experiment cells were treated with bumetanide 
and ouabain to inhibit Na
+-K
+-2Cl
- co-transporter and Na
+-K
+-ATPase 
respectively. KCC2 activity was then measured by 
86Rb
+ accumulation over a 
3-5min time course. Experiments were repeated with furosemide to inhibit 
KCC2 activity and the difference was recorded as furosemide-sensitive 
86Rb
+ 
influx, an indicator of KCC2 activity. As a negative control vector-transfected 
cells showed no 
86Rb
+ accumulation. By contrast, KCC2-FL WT-transfected 
cells showed a basal activity represented by 
86Rb
+ accumulation. This activity 
was increased by 15min pre-incubation with N-ethylmaleimide (NEM), an 
accepted activator of KCC2 (Payne, 1997) (Fig. 5.8). Interestingly, treatment of  
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Fig. 5.8 PKC-dependent phosphorylation of KCC2 Ser
940 modulates KCC2 
activity. K
+-Cl
- co-transport activity was monitored 48h after transfection by 
measuring the furosemide-sensitive 
86Rb
+ influx in cells expressing a series of 
KCC2 constructs or vector. Influx of 
86Rb
+ was linear for 10min in all KCC2 
constructs, and 3-5min influxes were routinely performed. HEK-293 cells were 
pretreated with 2μM bumetanide prior to the influx assay to inhibit endogenous 
Na
+-K
+-2Cl
- co-transporter activity and 100μM ouabain to inhibit endogenous 
Na
+-K
+-ATPase. The level of 
86Rb
+ influx is indicated under basal conditions 
or in the presence of 100nM PMA or 50μM NEM over a time course of 3-5min. 
[**, significantly different from basal condition (p < 0.001; value = 
mean±SEM, Student's t-test, n = 3)]   161
phorbol 12-myristate-13-acetate (PMA) significantly increased (p<0.001) 
KCC2 activity to 420±80.2% of basal condition (Fig. 5.8). Moreover, all other 
mutants of KCC2-FL showed comparable basal activity that was elevated by 
treatment with NEM; however, the effect of PMA was totally blocked by 
S940A alone (Fig. 5.8). This result demonstrated that KCC2 activity is 
modulated by direct phosphorylation of KCC2 Ser
940. The fact that mutant 
S940A is activated by NEM, indicates that NEM activates KCC2 in a manner 
that is perhaps not mediated by PKC. 
 
Discussion 
 
In this chapter, the effect of phosphorylation of KCC2 molecules on their cell 
surface stability and function was investigated. It was found that 
phosphorylation exerts a profound influence on KCC2 function in terms of its 
cell surface expression and co-transport function. KCC2 is a membrane protein 
that co-transports K
+ and Cl
- across neuronal membrane; therefore its cell 
surface expression is a major factor contributing to its overall function. A 
biotinylation method was first employed to investigate the cell surface 
expression of KCC2. Interestingly, results showed that activation of PKC 
significantly increased KCC2 expression at cell surface, which is in accord 
with a functional assay using 
86Rb
+ to study co-transport activity. The 
endocytic rate of cell surface KCC2 was measured and compared during 
phosphorylation. The investigation of endocytosis of cell surface KCC2 serves 
to provide a cellular mechanism to regulate its cell surface expression. It was 
found that phosphorylation of KCC2 by PKC significantly slowed its rate of   162
endocytosis, thereby increasing its cell surface expression. 
In addition to biotinylation, immunocytochemistry was employed as a tool to 
study the subcellular distribution of KCC2 under the effect of activation of 
PKC. Intriguingly, activation of PKC promoted an accumulation of KCC2 
proteins at the periphery of cells expressing KCC2 and also in the dendritic 
regions of cultured hippocampal neurons. These findings are also in accord 
with the biotinylation experiments and confirm the findings that activation of 
PKC promotes cell surface expression of KCC2 and hence its co-transport 
functions. 
 
The possible mechanism of such accumulation of KCC2 after PKC activation 
may be due to its reduced binding to the clathrin adaptor protein AP2 in the 
endocytic pathway (Kittler et al., 2005). Since the association between AP2 
and the protein is an essential step in this clathrin-mediated endocytosis, 
phosphorylation of KCC2 may structurally modify its binding site, and thus 
endocytosis is slowed. This in turn promotes an accumulation of KCC2 on cell 
surface. However, to date there is no direct evidence that Ser
940 is a binding 
motif of AP2 and future investigation will be needed. 
 
The role of Ser
940 in the functional regulation of KCC2 was also investigated in 
this chapter. Mutant S940A was compared to WT in the biotinylation and 
immunocytochemistry experiments. It was found that S940A completely 
blocked the effect of PKC activation on KCC2 cell surface accumulation. 
S940A appeared to be more stable on the cell surface in steady state than was 
WT KCC2. From the endocytosis assay it was shown that S940A was less   163
effectively endocytosed, suggesting that phosphorylation of Ser
940 is important 
for endocytosis of KCC2. This endocytosis assay also explained the fact that 
S940A is more stable on cell surface than is WT due to a reduced efficacy in 
endocytosis of KCC2 molecules in this phosphorylation-deficient mutant. 
 
An augmented level of cell surface KCC2 molecules in the S940A mutant may 
imply a higher overall co-transport activity. However, in the 
86Rb
+ flux assay it 
was found that the co-transport activity of S940A was not significantly 
different from that of WT, suggesting that S940A is intrinsically less effective 
in ion co-transport function. Furthermore, activation of PKC did not affect the 
co-transport function of S940A, indicating that functional regulation by PKC 
on this mutant is lost.   164
Chapter 6  Final discussion 
 
To date the roles that post-translational modifications of KCC2 play in 
regulating its functional expression have remained elusive; however, while 
there has been no documentation of direct phosphorylation of KCC2, this 
process has been implicated in regulating its activity (Bergeron et al., 2006; 
Wake et al., 2007). Based on recent studies of KCC2 and other members of 
cation chloride co-transporters, the objectives of this study were: 1) to 
demonstrate that KCC2 is phosphorylated on specific residue(s) and identify 
the kinase(s) activities responsible for this phosphorylation, 2) to develop a 
phospho-specific antibody as a molecular tool to examine KCC2 
phosphorylation, 3) to examine whether phosphorylation of KCC2 modulates 
its cell surface stability and membrane trafficking, and 4) to examine whether 
phosphorylation of KCC2 modulates its co-transport activities. This study 
therefore aims to provide a molecular understanding of the post-translational 
modifications that regulate KCC2 functional expression. 
 
6.1  Evidence that PKC phosphorylates Ser
940 in KCC2 
 
To study phosphorylation of KCC2, a consensus sequence motif search was 
initially performed to identify putative phosphorylation sites in KCC2. It was 
revealed that both intracellular N-tail and C-tail of KCC2 contain PKC 
phosphorylation sites and a tyrosine phosphorylation site (Fig. 1.1). To 
evaluate the results from this sequence motif search, in vitro kinase assays were 
employed. Fusion proteins of intracellular domains of KCC2 (N-tail and C-tail)   165
were constructed with a C-terminal His-tag and purified from bacteria. It was 
found that PKC could phosphorylate the fusion protein of the C-tail, but not the 
N-tail, of KCC2. Interestingly, a single mutation of Ser
940 in the C-tail 
intracellular domain of KCC2 significantly reduced the phosphorylation level 
of this fusion protein by PKC, suggesting an important role for Ser
940 in KCC2 
phosphorylation. 
 
To confirm my in vitro studies, the phosphorylation of KCC2 was examined in 
cultured HEK-293 cells and hippocampal neurons. Whole-cell labeling 
experiments using [
32P]orthophosphoric acid were performed. The results 
confirmed that: 1) there is basal phosphorylation of KCC2, 2) activation of 
PKC increases phosphorylation of KCC2, and 3) mutation of Ser
940 blocked the 
effect of PKC activation on KCC2 phosphorylation. These results provide the 
first evidence that KCC2 is directly phosphorylated. Significantly, Ser
940 lies in 
a region unique to KCC2 as compared to other KCC members, suggesting a 
distinct role in neuronal-specific regulation. 
 
The phosphorylation of KCC2 was also analyzed in hippocampal neurons. This 
analysis revealed that activation of PKC increases phosphorylation in serine 
residues and induces tyrosine phosphorylation (Fig. 3.21). Interestingly, the 
pharmacological agent used in this experiment was specific to activation of 
PKC. The observed tyrosine phosphorylation of KCC2 in neurons after PKC 
activation therefore suggested that tyrosine kinase may be activated by a PKC-
dependent pathway which in turn phosphorylates KCC2. Interestingly, Pyk2, a 
member of the focal adhesion kinase family, is implicated as a molecular link   166
between PKC and Src (Lev et al., 1995). After activation by PKC, Pyk2 
autophosphorylates on its residue Tyr
402 (Girault et al., 1999), creates a Src 
homology 2 (SH2) ligand through which Pyk2 binds to the SH2 domain of Src 
(Dikic et al., 1996) and activates Src kinase by relieving autoinhibition 
(Thomas and Brugge, 1997). In chapter 3, experiments showed that tyrosine 
phosphorylation of KCC2 is strictly regulated by an unknown tyrosine 
phosphatase and Src kinase. 
 
The study of phosphorylation at Ser
940 was extended by the development of a 
phospho-specific antibody of KCC2. This antibody, p-S940, proved to be 
specific to the phosphorylated Ser
940 in a number of tests including western 
blotting and immunofluorescence staining. This tool was first employed to 
study the dephosphorylation of Ser
940. It is known that dephosphorylation of 
the serine residue can be carried out by serine/threonine-specific protein 
phosphatases PP1, PP2A, PP2B and PP2C (Cohen, 1989). Western blotting 
using p-S940 in the presence of phosphatase inhibitor okadaic acid showed that 
PP1 and PP2A are responsible for dephosphorylation of KCC2 at Ser
940. These 
results were confirmed by in vitro phosphatase assay. 
 
6.2  Phosphorylation of Ser
940 modulates KCC2 trafficking and activity 
 
Phosphorylation is the addition of a negatively charged phosphate group to 
serine, threonine or tyrosine residues of a protein (Edelman et al., 1987; 
Carpenter, 1992). This process usually results in a change of protein 
conformation and micro-domain environment of a protein. Studies have shown   167
that phosphorylation regulates numerous cellular processes including the 
intracellular trafficking of proteins (Billingsley and Kincaid, 1997), the 
degradation and the recycling of proteins (Evans and Cousin, 2005). In chapter 
5, the effects of phosphorylation of KCC2 on its cell surface stability and 
functional activity were documented. 
 
It was demonstrated that PKC activation increases cell surface expression of 
KCC2. This change in cell surface stability was blocked by a PKC-specific 
inhibitor and mutation of Ser
940. These results were confirmed using 
immunocytochemistry methods. Importantly, co-transport activity of KCC2 
was also shown to be increased by PKC activation. This increase was blocked 
by a PKC-specific inhibitor and mutation of Ser
940. 
 
The mechanism by which cell surface expression of KCC2 is modulated by 
PKC activity was also investigated. Steady-state cell surface expression of 
membrane proteins is dependent upon the relative rates of endocytosis, 
degradation and insertion (Turner et al., 1999; Evans and Cousin, 2005; Kittler 
et al., 2005). It was found that endocytosis of KCC2 was significantly reduced 
upon PKC activation, explaining the increase in cell surface stability observed 
in previous sections. Mutation of Ser
940 confirmed that: 1) phosphorylation of 
Ser
940 slows endocytosis of KCC2, and 2) Ser
940 is responsible for regulation of 
KCC2 cell surface stability by PKC activity. Together, these results suggest a 
distinct role for Ser
940 in KCC2 trafficking (Fig. 6.1).   168
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Fig. 6.1 Phospho-dependent modulation of KCC2 cell surface stability and 
function. A. Cell surface stability of KCC2 is affected by its endocytosis from 
cell membrane, degradation in intracellular compartment and re-insertion into 
cell membrane. Phosphorylation of KCC2 by PKC blocks the endocytosis of 
KCC2 while dephosphorylation of KCC2 mediated through PP1 and PP2A 
promotes endocytosis. B. At steady-state KCC2 plays a central role as the 
major Cl
- extruder in neurons. Phosphorylation of KCC2 increases its cell 
surface expression by decreasing its endocytosis and possibly increasing its 
insertion rate. This leads to an overall increase in co-transport function.   169
6.3  Modulation of KCC2 activity and its implication in neurological 
disorders 
 
It has been shown that KCC2 activity generates a transmembrane Cl
- gradient 
in mature neurons such that activation of GABAA receptor results in an inward 
Cl
- current leading to hyperpolarization (Rivera et al., 1999). During neuronal 
development, the expression of KCC2 is up-regulated while the Cl
- importer 
NKCC1 is down-regulated (Wang et al., 2002). To date KCC2 has been found 
to function primarily as a molecular switch to determine the GABAergic 
response during neuronal development and the strength of synaptic inhibition 
in mature neurons (Rivera et al., 1999). 
 
Since the expression and activity of KCC2 are highly associated with inhibitory 
synaptic transmission, precise regulation of KCC2 is crucial for fine-tuning of 
neuronal network activity. Malfunction or reduced expression of KCC2 has 
been reported in disease models related to epilepsy, a state in which neuronal 
network inhibition is compromised (Reid et al., 2001; Jin et al., 2005; Pathak et 
al., 2007; Shimizu-Okabe et al., 2007). There is also increasing evidence that 
disruption of the KCC2 gene leads to hyperexcitability or a decrease in the 
threshold of seizure generation (Woo et al., 2002; Tornberg et al., 2005); thus 
by regulating the activity of KCC2, the efficacy of inhibitory neurotransmitter 
can be modified. Results presented in this thesis show that PKC and tyrosine 
kinases regulate KCC2 phosphorylation. Activation of PKC increases co-
transport function of KCC2 by increasing its cell surface stability, suggesting 
that PKC is an important target for altering neuronal inhibition. Furthermore, in   170
epilepsy models PKC and tyrosine kinase are regulated in an opposite manner 
(Funke et al., 1998; Pathak et al., 2007). This suggests that phosphorylation by 
PKC and tyrosine kinase may have profound effects on KCC2 function in 
epilepsy. 
 
A recent study has shown that KCC2 is vital in neuronal development as it 
interacts structurally with cytoskeletal elements depending on the intracellular 
C-terminal domain of KCC2 (Li et al., 2007). However, this intracellular 
domain spans over 500 amino acids in length and the specific region 
responsible for this interaction remains unknown. 
 
6.4 Future  directions 
 
In this thesis direct phosphorylation of KCC2 was first described and the 
functional consequences of this covalent modification were examined. 
However, KCC2 can also be regulated by other cellular modulators such as 
glycosylation, alkylation, protein interaction and ubiquitination. It will be 
interesting to evaluate whether KCC2 activity and its intracellular trafficking is 
affected by these cellular processes. For example, site-directed mutagenesis of 
putative glycosylation sites may be performed to investigate the effect of 
glycosylation on KCC2 cell surface expression and activity. Furthermore, the 
role of tyrosine phosphorylation in regulation of KCC2 needs to be explored. 
Activators or inhibitors of PTK can be employed to investigate the effect of 
tyrosine phosphorylation on KCC2 activity. It also remains unclear how KCC2 
is endocytosed back to the intracellular domain, although the mechanism likely   171
involves the clathrin-coated pits of the AP2 complex. Experiments such as in 
vitro binding assay can be performed to investigate the association between 
KCC2 and AP2 complex. 
 
Functionally, phosphorylation enhances KCC2 activity by increasing its cell 
surface expression. However, whether this process also modulates the intrinsic 
activity of KCC2 (i.e. the co-transport activity of each KCC2 molecule per se) 
requires further investigation. 
 
A linkage between functional modulation of KCC2 activity and human 
pathology can be drawn. It is evident that KCC2 contributes to the onset of 
epilepsy due to an alteration in transmembrane Cl
- potential. Therefore an 
animal model with a mutated Ser
940 site engineered into its KCC2 gene will 
give insights into how this residue is involved in KCC2 function in vivo and in 
such neuronal disorders as epilepsy. By deciphering the molecular mechanism 
that regulates KCC2 in disease states, therapeutic strategies can be designed 
based on enhancing KCC2 function. 
 
6.5 Summary 
 
KCC2 is subject to direct phosphorylation by PKC and tyrosine kinase Src in 
neurons. In particular, Ser
940 in the intracellular domain of KCC2 is a major 
substrate of PKC. Studies using a phospho-specific antibody of KCC2 revealed 
that PKC and protein phosphatases PP1 and PP2A regulate phosphorylation of 
Ser
940. Activation of PKC increases cell surface expression of KCC2 and   172
promotes a subcellular distribution of KCC2 towards the axonal membrane. 
The accumulation of cell surface KCC2 upon PKC activation is due to a 
reduction in endocytosis, a process blocked by mutation of Ser
940. PKC 
activation also increases co-transport activity of KCC2. Mutation of Ser
940 
renders KCC2 insensitive to regulation by PKC. Together, this thesis describes 
an important regulatory role for PKC phosphorylation on cell surface 
expression, endocytosis and co-transport activity of KCC2 through the site 
Ser
940 found in the intracellular domain of this co-transporter.   173
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